<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genome Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Genome Biol</journal-id>
<journal-title-group>
<journal-title>Genome Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1474-7596</issn>
<issn pub-type="epub">1474-760X</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31409373</article-id>
<article-id pub-id-type="pmc">6693144</article-id>
<article-id pub-id-type="publisher-id">1753</article-id>
<article-id pub-id-type="doi">10.1186/s13059-019-1753-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Screening for genes that accelerate the epigenetic aging clock in humans reveals a role for the H3K36 methyltransferase NSD1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2285-3317</contrib-id>
<name>
<surname>Martin-Herranz</surname>
<given-names>Daniel E.</given-names>
</name>
<address>
<email>dem44@ebi.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aref-Eshghi</surname>
<given-names>Erfan</given-names>
</name>
<address>
<email>eeshghi@uwo.ca</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonder</surname>
<given-names>Marc Jan</given-names>
</name>
<address>
<email>bonder.m.j@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stubbs</surname>
<given-names>Thomas M.</given-names>
</name>
<address>
<email>tom@chronomics.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choufani</surname>
<given-names>Sanaa</given-names>
</name>
<address>
<email>Sanaa.choufani@sickkids.ca</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weksberg</surname>
<given-names>Rosanna</given-names>
</name>
<address>
<email>rweksb@sickkids.ca</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stegle</surname>
<given-names>Oliver</given-names>
</name>
<address>
<email>oliver.stegle@ebi.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sadikovic</surname>
<given-names>Bekim</given-names>
</name>
<address>
<email>Bekim.Sadikovic@lhsc.on.ca</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Reik</surname>
<given-names>Wolf</given-names>
</name>
<address>
<email>wolf.reik@babraham.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff8">8</xref>
<xref ref-type="aff" rid="Aff9">9</xref>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Thornton</surname>
<given-names>Janet M.</given-names>
</name>
<address>
<email>thornton@ebi.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label>European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK </aff>
<aff id="Aff2"><label>2</label>Chronomics Ltd., Cambridge, UK </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8884</institution-id><institution-id institution-id-type="GRID">grid.39381.30</institution-id><institution>Department of Pathology and Laboratory Medicine, </institution><institution>Western University, </institution></institution-wrap>London, Canada </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9132 1600</institution-id><institution-id institution-id-type="GRID">grid.412745.1</institution-id><institution>Molecular Genetics Laboratory, Molecular Diagnostics Division, </institution><institution>London Health Sciences Centre, </institution></institution-wrap>London, Canada </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0495 846X</institution-id><institution-id institution-id-type="GRID">grid.4709.a</institution-id><institution>European Molecular Biology Laboratory, </institution><institution>Genome Biology Unit, </institution></institution-wrap>Heidelberg, Germany </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0473 9646</institution-id><institution-id institution-id-type="GRID">grid.42327.30</institution-id><institution>Genetics and Genome Biology Program, Research Institute, </institution><institution>The Hospital for Sick Children, </institution></institution-wrap>Toronto, Canada </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0492 0584</institution-id><institution-id institution-id-type="GRID">grid.7497.d</institution-id><institution>Division of Computational Genomics and Systems Genetics, </institution><institution>German Cancer Research Center (DKFZ), </institution></institution-wrap>Heidelberg, Germany </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0694 2777</institution-id><institution-id institution-id-type="GRID">grid.418195.0</institution-id><institution>Epigenetics Programme, </institution><institution>The Babraham Institute, </institution></institution-wrap>Cambridge, UK </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution>Centre for Trophoblast Research, </institution><institution>University of Cambridge, </institution></institution-wrap>Cambridge, UK </aff>
<aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0606 5382</institution-id><institution-id institution-id-type="GRID">grid.10306.34</institution-id><institution>Wellcome Sanger Institute, </institution></institution-wrap>Hinxton, Cambridge, UK </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>14</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>14</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>20</volume>
<elocation-id>146</elocation-id>
<history>
<date date-type="received">
<day>8</day>
<month>2</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>3</day>
<month>7</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Epigenetic clocks are mathematical models that predict the biological age of an individual using DNA methylation data and have emerged in the last few years as the most accurate biomarkers of the aging process. However, little is known about the molecular mechanisms that control the rate of such clocks. Here, we have examined the human epigenetic clock in patients with a variety of developmental disorders, harboring mutations in proteins of the epigenetic machinery.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par2">Using the Horvath epigenetic clock, we perform an unbiased screen for epigenetic age acceleration in the blood of these patients. We demonstrate that loss-of-function mutations in the H3K36 histone methyltransferase NSD1, which cause Sotos syndrome, substantially accelerate epigenetic aging. Furthermore, we show that the normal aging process and Sotos syndrome share methylation changes and the genomic context in which they occur. Finally, we found that the Horvath clock CpG sites are characterized by a higher Shannon methylation entropy when compared with the rest of the genome, which is dramatically decreased in Sotos syndrome patients.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par3">These results suggest that the H3K36 methylation machinery is a key component of the <italic>epigenetic maintenance system</italic> in humans, which controls the rate of epigenetic aging, and this role seems to be conserved in model organisms. Our observations provide novel insights into the mechanisms behind the epigenetic aging clock and we expect will shed light on the different processes that erode the human epigenetic landscape during aging.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s13059-019-1753-9) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Aging</kwd>
<kwd>Epigenetics</kwd>
<kwd>DNA methylation</kwd>
<kwd>Epigenetic clock</kwd>
<kwd>Biological age</kwd>
<kwd>Developmental disorder</kwd>
<kwd>Sotos syndrome</kwd>
<kwd>H3K36 methylation</kwd>
<kwd>NSD1</kwd>
<kwd>Methylation entropy</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100013060</institution-id>
<institution>European Molecular Biology Laboratory</institution>
</institution-wrap>
</funding-source>
<award-id>Predoctoral fellowship (40579)</award-id>
<award-id>EMBL Interdisciplinary Postdoc (EI3POD) program under Marie SkÅodowska-Curie Actions COFUND (664726)</award-id>
<principal-award-recipient>
<name>
<surname>Martin-Herranz</surname>
<given-names>Daniel E.</given-names>
</name>
<name>
<surname>Bonder</surname>
<given-names>Marc Jan</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>Â© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par20">Aging is normally defined as the time-dependent functional decline which increases vulnerability to common diseases and death in most organisms [<xref ref-type="bibr" rid="CR1">1</xref>]. However, the molecular processes that drive the emergence of age-related diseases are only beginning to be elucidated. With the passage of time, dramatic and complex changes accumulate in the epigenome of cells, from yeast to humans, pinpointing epigenetic alterations as one of the hallmarks of aging [<xref ref-type="bibr" rid="CR1">1</xref>â<xref ref-type="bibr" rid="CR4">4</xref>].</p>
<p id="Par21">Our understanding of the aging process has historically been hampered by the lack of tools to accurately measure it. In recent years, epigenetic clocks have emerged as powerful biomarkers of the aging process across mammals [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], including humans [<xref ref-type="bibr" rid="CR7">7</xref>â<xref ref-type="bibr" rid="CR9">9</xref>], mouse [<xref ref-type="bibr" rid="CR10">10</xref>â<xref ref-type="bibr" rid="CR14">14</xref>], dogs and wolves [<xref ref-type="bibr" rid="CR15">15</xref>], and humpback whales [<xref ref-type="bibr" rid="CR16">16</xref>]. Epigenetic clocks are mathematical models that are trained to predict chronological age using the DNA methylation status of a small number of CpG sites in the genome. The most widely used multi-tissue epigenetic clock in humans was developed by Steve Horvath in 2013 [<xref ref-type="bibr" rid="CR8">8</xref>]. Interestingly, deviations of the epigenetic (biological) age from the expected chronological age (aka epigenetic age acceleration or EAA) have been associated with many conditions in humans, including time-to-death [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], HIV infection [<xref ref-type="bibr" rid="CR19">19</xref>], Down syndrome [<xref ref-type="bibr" rid="CR20">20</xref>], obesity [<xref ref-type="bibr" rid="CR21">21</xref>], Werner syndrome [<xref ref-type="bibr" rid="CR22">22</xref>], and Huntingtonâs disease [<xref ref-type="bibr" rid="CR23">23</xref>]. On the contrary, children with multifocal developmental dysfunctions (syndrome X), which seem to evade aging, did not display slower epigenetic aging in a previous study [<xref ref-type="bibr" rid="CR24">24</xref>]. In mice, the epigenetic clock is slowed down by dwarfism and calorie restriction [<xref ref-type="bibr" rid="CR11">11</xref>â<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR25">25</xref>] and is accelerated by ovariectomy and high-fat diet [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Furthermore, in vitro reprogramming of somatic cells into iPSCs reduces epigenetic age to values close to zero both in humans [<xref ref-type="bibr" rid="CR8">8</xref>] and mice [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], which opens the door to potential rejuvenation therapies [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>].</p>
<p id="Par22">Epigenetic clocks can be understood as a proxy to quantify the changes of the epigenome with age. However, little is known about the molecular mechanisms that determine the rate of these clocks. Steve Horvath proposed that the multi-tissue epigenetic clock captures the workings of an <italic>epigenetic maintenance system</italic> [<xref ref-type="bibr" rid="CR8">8</xref>]. Recent GWAS studies have found several genetic variants associated with epigenetic age acceleration in genes such as <italic>TERT</italic> (the catalytic subunit of telomerase) [<xref ref-type="bibr" rid="CR28">28</xref>], <italic>DHX57</italic> (an ATP-dependent RNA helicase) [<xref ref-type="bibr" rid="CR29">29</xref>], or <italic>MLST8</italic> (a subunit of both mTORC1 and mTORC2 complexes) [<xref ref-type="bibr" rid="CR29">29</xref>]. Nevertheless, to our knowledge, no genetic variants in epigenetic modifiers have been found and the molecular nature of this hypothetical system is unknown to this date.</p>
<p id="Par23">We decided to take a reverse genetics approach and look at the behavior of the epigenetic clock in patients with developmental disorders, many of which harbor mutations in proteins of the epigenetic machinery [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. We performed an unbiased screen for epigenetic age acceleration and found that Sotos syndrome accelerates epigenetic aging, potentially revealing a role of H3K36 methylation maintenance in the regulation of the rate of the epigenetic clock.</p>
</sec>
<sec id="Sec2">
<title>Results</title>
<sec id="Sec3">
<title>Screening for epigenetic age acceleration is improved when correcting for batch effects</title>
<p id="Par24">The main goal of this study is to identify genes, mainly components of the epigenetic machinery, that can affect the rate of epigenetic aging in humans (as measured by Horvathâs epigenetic clock) [<xref ref-type="bibr" rid="CR8">8</xref>]. For this purpose, we conducted an unbiased screen for epigenetic age acceleration (EAA) in samples from patients with developmental disorders that we could access and for which genome-wide DNA methylation data was available (TableÂ <xref ref-type="table" rid="Tab1">1</xref>, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM2">2</xref>). Horvathâs epigenetic clock, unlike other epigenetic clocks available in the literature, works across the entire human lifespan (even in prenatal samples), and it is therefore well suited for this type of analysis [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. All the DNA methylation data were generated from the blood using the Illumina HumanMethylation450 array (450K array).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Overview of the developmental disorders that were included in the screening (total <italic>N</italic>â=â367) after quality control (QC) and filtering (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section and Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>a)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Developmental disorder</th><th>Gene(s) involved</th><th>Gene(s) function</th><th>Molecular cause</th><th>Number</th><th>Age range (years)</th></tr></thead><tbody><tr><td>Angelman</td><td><italic>UBE3A</italic></td><td>Ubiquitin-protein ligase E3A</td><td>Imprinting, mutation</td><td>14</td><td>1 to 55</td></tr><tr><td>Autism spectrum disorder (ASD)</td><td>â</td><td>â</td><td>â</td><td>119</td><td>1.83 to 35.16</td></tr><tr><td>Alpha thalassemia/mental retardation X-linked syndrome (ATR-X)</td><td><italic>ATRX</italic></td><td>Chromatin remodeling</td><td>Mutation</td><td>15</td><td>0.7 to 27</td></tr><tr><td>Claes-Jensen</td><td><italic>KDM5C</italic></td><td>H3K4 demethylase</td><td>Mutation</td><td>10</td><td>2 to 42</td></tr><tr><td>Coffin-Lowry</td><td><italic>RPS6KA3</italic></td><td>Serine/threonine kinase</td><td>Mutation</td><td>10</td><td>1.3 to 22.8</td></tr><tr><td>Floating-Harbor</td><td><italic>SRCAP</italic></td><td>Chromatin remodeling</td><td>Mutation</td><td>17</td><td>4 to 42</td></tr><tr><td>Fragile X syndrome (FXS)</td><td><italic>FMR1</italic></td><td>Translational control</td><td>Mutation (CGG expansion)</td><td>32</td><td>0.08 to 48</td></tr><tr><td>Kabuki</td><td><italic>KMT2D</italic></td><td>H3K4 methyltransferase</td><td>Mutation</td><td>46</td><td>0 to 24.1</td></tr><tr><td>Noonan</td><td><italic>PTPN11</italic>, <italic>RAF1</italic>, <italic>SOS1</italic></td><td>RAS/MAPK signaling</td><td>Mutation</td><td>15, 11, 14</td><td>0.2 to 49</td></tr><tr><td>Rett</td><td><italic>MECP2</italic></td><td>Transcriptional repression</td><td>Mutation</td><td>15</td><td>1 to 34</td></tr><tr><td>Saethre-Chotzen</td><td><italic>TWIST1</italic></td><td>Transcription factor</td><td>Mutation</td><td>22</td><td>0 to 38</td></tr><tr><td>Sotos</td><td><italic>NSD1</italic></td><td>H3K36 methyltransferase</td><td>Mutation</td><td>20</td><td>1.6 to 41</td></tr><tr><td>Weaver</td><td><italic>EZH2</italic></td><td>H3K27 methyltransferase</td><td>Mutation</td><td>7</td><td>2.58 to 43</td></tr></tbody></table></table-wrap></p>
<p id="Par25">The main step in the screening methodology is to compare the EAA distribution for the samples with a given developmental disorder against a robust control (Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>a). In our case, the control set was obtained from human blood samples in a healthy population of individuals that matched the age range of the developmental disorder samples (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM3">3</xref>). Given that the EAA reflects deviations between the epigenetic (biological) age and the chronological age of a sample, we would expect the EAA distributions of the controls to be centered around zero, which is equivalent to the situation when the median absolute error (MAE) of the model prediction is close to zero (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section). This was not the case for the samples obtained from several control batches (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1A, S1B), both in the case of EAA models with and without cell composition correction (CCC). It is worth noting that these results were obtained even after applying the internal normalization step against a blood gold standard suggested by Horvath [<xref ref-type="bibr" rid="CR8">8</xref>]. Therefore, we hypothesized that part of the deviations observed might be caused by technical variance that was affecting epigenetic age predictions in the different batches.<fig id="Fig1"><label>Fig. 1</label><caption><p>Screening for epigenetic age acceleration (EAA) is improved when correcting for batch effects. <bold>a</bold> Flow diagram that portrays an overview of the different analyses that are carried out in the raw DNA methylation data (IDAT files) from human blood for cases (developmental disorders samples) and controls (healthy samples). The control samples are filtered to match the age range of the cases (0â55âyears). The cases are filtered based on the number of âadultâ samples available (for each disorder, at least 5 samples, with 2 of them with an age â¥â20âyears). More details can be found in the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section. QC, quality control; DMPs, differentially methylated positions. <bold>b</bold> Scatterplot showing the values of the first two principal components (PCs) for the control samples after performing PCA on the control probes of the 450K arrays. Each point corresponds to a different control sample, and the colors represent the different batches. The different batches cluster together in the PCA space, showing that the control probes indeed capture technical variation. Please note that all the PCA calculations were done with more samples from cases and controls than those that were included in the final screening since it was performed before the filtering step (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section and Fig.Â 1a). <bold>c</bold> Plot showing how the median absolute error (MAE) of the prediction in the control samples, that should tend to zero, is reduced when the PCs capturing the technical variation are included as part of the modeling strategy (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section). The dashed line represents the optimal number of PCs (17) that was finally used. The optimal mean MAE is calculated as the average MAE between the green and purple lines. CCC, cell composition correction. <bold>d</bold> Distribution of the EAA with cell composition correction (CCC) for the different control batches, after applying batch effect correction</p></caption><graphic id="MO1" xlink:href="13059_2019_1753_Fig1_HTML"></graphic></fig></p>
<p id="Par26">We decided to correct for the potential batch effects by making use of the control probes present on the 450K array, which have been shown to carry information about unwanted variation from a technical source (i.e., technical variance) [<xref ref-type="bibr" rid="CR33">33</xref>â<xref ref-type="bibr" rid="CR35">35</xref>]. Performing principal components analysis (PCA) on the raw intensities of the control probes showed that the first two components (PCs) capture the batch structure in both controls (Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>b) and cases (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1C). Including the first 17 PCs as part of the EAA modeling strategy (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section), which together accounted for 98.06% of the technical variance in controls and cases (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1D), significantly reduced the median absolute error (MAE) of the predictions in the controls (MAE <sub>without CCC</sub>â=â2.8211âyears, MAE <sub>with CCC</sub>â=â2.7117âyears, mean MAEâ=â2.7664âyears, Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>c). These values are below the original MAE reported by Horvath in his test set (3.6âyears) [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
<p id="Par27">Finally, deviations from a median EAA close to zero in some of the control batches after batch effect correction (Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>d, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1E) could be explained by other variables, such as a small batch size or an overrepresentation of young samples (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1F). The latter is a consequence of the fact that Horvathâs model underestimates the epigenetic ages of older samples, a phenomenon which has also been observed by other authors [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. If there is a high number of old samples (generally &gt;â60âyears) in the control model, this can lead to a lower model slope, which would incorrectly assign negative EAA to young samples. This highlights the importance of having an age distribution in the control samples that matches that of the cases to be tested for differences in EAA.</p>
<p id="Par28">Thus, we have shown that correcting for batch effects in the context of the epigenetic clock is important, especially when combining datasets from different sources for meta-analysis purposes. Batch effect correction is essential to remove technical variance that could affect the epigenetic age of the samples and confound biological interpretation.</p>
</sec>
<sec id="Sec4">
<title>Sotos syndrome accelerates epigenetic aging</title>
<p id="Par29">Once we had corrected for potential batch effects in the data, we compared the epigenetic age acceleration (EAA) distributions between each of the developmental disorders studied and our control set. For a given sample, a positive EAA indicates that the epigenetic (biological) age of the sample is higher than the one expected for someone with that chronological age. In other words, it means that the epigenome of that person resembles the epigenome of an older individual. The opposite is true when a negative EAA is found (i.e., the epigenome looks younger than expected).</p>
<p id="Par30">For the main screen, we selected those control samples with the same age range as the one present when aggregating all the cases (0 to 55âyears), since this permits the development of a common control (background) model and to compare the statistical significance of the results across developmental disorders. Only those developmental disorders that satisfied our filtering criteria were considered for the screen (at least 5 samples available for the developmental disorder, with 2 of them presenting a chronological age â¥â20âyears, Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>a, TableÂ <xref ref-type="table" rid="Tab1">1</xref> and AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM2">2</xref>). Given that the blood composition changes with age (changes in the different cell type proportions, which can affect bulk DNA methylation measurements), we used models with and without cell composition correction (CCC), correcting for batch effects in both of them (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section). It is important to mention that EAA<sub>with CCC</sub> is conceptually similar to the previously reported measure of âintrinsic EAAâ (IEAA) [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR38">38</xref>].</p>
<p id="Par31">The results from the screen are portrayed in Fig.Â <xref ref-type="fig" rid="Fig2">2</xref>a. Most syndromes do not show evidence of accelerated epigenetic aging, but Sotos syndrome presents a clear positive EAA (median EAA<sub>with CCC</sub>â=â+â7.64âyears, median EAA<sub>without CCC</sub>â=â+â7.16âyears), with <italic>p</italic> values considerably below the significance level of 0.01 after Bonferroni correction (<italic>p</italic> value<sub>corrected, with CCC</sub>â=â3.40âÃâ10<sup>â9</sup>, <italic>p</italic> value<sub>corrected, without CCC</sub>â=â2.61âÃâ10<sup>â7</sup>). Additionally, Rett syndrome (median EAA<sub>with CCC</sub>â=â+â2.68âyears, median EAA<sub>without CCC</sub>â=â+â2.46âyears, <italic>p</italic> value<sub>corrected, with CCC</sub>â=â0.0069, <italic>p</italic> value<sub>corrected, without CCC</sub>â=â0.0251) and Kabuki syndrome (median EAA<sub>with CCC</sub>â=âââ1.78âyears, median EAA<sub>without CCC</sub>â=âââ2.25âyears, <italic>p</italic> value<sub>corrected, with CCC</sub>â=â0.0011, <italic>p</italic> value<sub>corrected, without CCC</sub>â=â0.0035) reach significance, with a positive and negative EAA, respectively. Finally, fragile X syndrome (FXS) shows a positive EAA trend (median EAA<sub>with CCC</sub>â=â+â2.44âyears, median EAA<sub>without CCC</sub>â=â+â2.88âyears) that does not reach significance in our screen (<italic>p</italic> value<sub>corrected, with CCC</sub>â=â0.0680, <italic>p</italic> value<sub>corrected, without CCC</sub>â=â0.0693).<fig id="Fig2"><label>Fig. 2</label><caption><p>Sotos syndrome accelerates epigenetic aging. <bold>a</bold> Screening for epigenetic age acceleration (EAA) in developmental disorders. The upper panel shows the <italic>p</italic> values derived from comparing the EAA distributions for the samples in a given developmental disorder and the control (two-sided Wilcoxonâs test). The dashed green line displays the significance level of <italic>Î±</italic>â=â0.01 after Bonferroni correction. The bars above the green line reach statistical significance. The lower panel displays the actual EAA distributions, which allows assessing the direction of the EAA (positive or negative). In red: EAA model with cell composition correction (CCC). In blue: EAA model without CCC. ASD, autism spectrum disorder; ATR-X, alpha thalassemia/mental retardation X-linked syndrome; FXS, fragile X syndrome. <bold>b</bold> Scatterplot showing the relation between epigenetic age (<italic>DNAmAge</italic>) according to Horvathâs model [<xref ref-type="bibr" rid="CR8">8</xref>] and chronological age of the samples for Sotos (orange) and control (gray). Each sample is represented by one point. The black dashed line represents the diagonal to aid visualization. <bold>c</bold> Scatterplot showing the relation between the epigenetic age acceleration (EAA) and chronological age of the samples for Sotos (orange) and control (gray). Each sample is represented by one point. The yellow line represents the linear model EAAâ~âAge, with the standard error shown in the light yellow shade. <bold>d</bold> Scatterplot showing the relation between the score for the epigenetic mitotic clock (<italic>pcgtAge</italic>) [<xref ref-type="bibr" rid="CR39">39</xref>] and chronological age of the samples for Sotos (orange) and control (gray). Each sample is represented by one point. A higher value of <italic>pcgtAge</italic> is associated with a higher number of cell divisions in the tissue. <bold>e</bold> Scatterplot showing the relation between the epigenetic mitotic clock (<italic>pcgtAge</italic>) acceleration and chronological age of the samples for Sotos (orange) and control (gray). Each sample is represented by one point. The yellow line represents the linear model <italic>pcgtAge</italic><sub>acceleration</sub>â~âAge, with the standard error shown in the light yellow shade</p></caption><graphic id="MO2" xlink:href="13059_2019_1753_Fig2_HTML"></graphic></fig></p>
<p id="Par32">Next, we tested the effect of changing the median age used to build the healthy control model (i.e., the median age of the controls) on the screening results (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2A). Sotos syndrome is robust to these changes, whilst Rett, Kabuki, and FXS are much more sensitive to the control model used. This again highlights the importance of choosing an appropriate age-matched control when testing for epigenetic age acceleration, given that Horvathâs epigenetic clock underestimates epigenetic age for advanced chronological ages [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>].</p>
<p id="Par33">Moreover, all but one of the Sotos syndrome patients (19/20â=â95%) show a consistent deviation in EAA (with CCC) in the same direction (Fig.Â <xref ref-type="fig" rid="Fig2">2</xref>b, c), which is not the case for the rest of the disorders, with the exception of Rett syndrome (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2B). Even though the data suggest that there are already some methylomic changes at birth, the EAA seems to increase with age in the case of Sotos patients (Fig.Â <xref ref-type="fig" rid="Fig2">2</xref>c; <italic>p</italic> values for the slope coefficient of the EAAâ~âAge linear regression: <italic>p</italic> value<sub>with CCC</sub>â=â0.00569, <italic>p</italic> value<sub>without CCC</sub>â=â0.00514). This could imply that at least some of the changes that normally affect the epigenome with age are happening at a faster rate in Sotos syndrome patients during their lifespan (as opposed to the idea that the Sotos epigenetic changes are only acquired during prenatal development and remain constant afterwards). Nevertheless, this increase in EAA with chronological age is highly influenced by a single patient with a chronological age of 41âyears (i.e., if this patient is removed, the <italic>p</italic> values for the slope coefficient are <italic>p</italic> value<sub>with CCC</sub>â=â0.1785 and <italic>p</italic> value<sub>without CCC</sub>â=â0.1087 respectively). Therefore, more data of older Sotos patients are required to be certain about the dynamics of these methylomic changes.</p>
<p id="Par34">In order to further validate the epigenetic age acceleration observed in Sotos patients, we calculated their epigenetic age according to other widely used epigenetic clocks: Hannumâs clock [<xref ref-type="bibr" rid="CR9">9</xref>], Linâs clock [<xref ref-type="bibr" rid="CR40">40</xref>], and the skin-blood clock [<xref ref-type="bibr" rid="CR41">41</xref>]. These analyses confirmed that Sotos patients clearly present accelerated epigenetic aging when compared with healthy individuals (with the exception of the EAA<sub>without CCC</sub> in the skin-blood clock, which showed the same trend but did not reach significance; AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2C-E).</p>
<p id="Par35">Finally, we investigated whether Sotos syndrome leads to a higher rate of (stem) cell division in the blood when compared with our healthy population. We used a reported epigenetic mitotic clock (<italic>pcgtAge</italic>) that makes use of the fact that some CpGs in promoters that are bound by Polycomb group proteins become hypermethylated with age. This hypermethylation correlates with the number of cell divisions in the tissue and is also associated with an increase in cancer risk [<xref ref-type="bibr" rid="CR39">39</xref>]. We found a trend suggesting that the epigenetic mitotic clock might be accelerated in Sotos patients (<italic>p</italic> valueâ=â0.0112, Fig.Â <xref ref-type="fig" rid="Fig2">2</xref>d, e), which could explain the higher cancer predisposition reported in these patients and might relate to their overgrowth [<xref ref-type="bibr" rid="CR42">42</xref>]. Again, this trend could be influenced by the 41-year-old Sotos patient (after removing this patient: <italic>p</italic> valueâ=â0.0245), and more data of older Sotos patients is required to confirm this observation.</p>
<p id="Par36">Consequently, we report that individuals with Sotos syndrome present an accelerated epigenetic age, which makes their epigenome look, on average, more than 7âyears older than expected. These changes could be the consequence of a higher ticking rate of the epigenetic clock (or at least part of its machinery), with epigenetic age acceleration potentially increasing during lifespan: the youngest Sotos patient (1.6âyears) has an EAA<sub>with CCC</sub>â=â5.43âyears and the oldest (41âyears) has an EAA<sub>with CCC</sub>â=â24.53âyears. Additionally, Rett syndrome, Kabuki syndrome, and fragile X syndrome could also have their epigenetic ages affected, but more evidence is required to be certain about this conclusion.</p>
</sec>
<sec id="Sec5">
<title>Physiological aging and Sotos syndrome share methylation changes and the genomic context in which they occur</title>
<p id="Par37">Sotos syndrome is caused by loss-of-function heterozygous mutations in the <italic>NSD1</italic> gene, a histone H3K36 methyltransferase [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. These mutations lead to a specific DNA methylation signature in Sotos patients, potentially due to the crosstalk between the histone and DNA methylation machinery [<xref ref-type="bibr" rid="CR44">44</xref>]. In order to gain a more detailed picture of the reported epigenetic age acceleration, we decided to compare the genome-wide (or at least array-wide) changes observed in the methylome during aging with those observed in Sotos syndrome. For this purpose, we identified differentially methylated positions (DMPs) for both conditions (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section). Aging DMPs (aDMPs), were composed almost equally of CpG sites that gain methylation with age (i.e., become hypermethylated, 51.69%) and CpG sites that lose methylation with age (i.e., become hypomethylated, 48.31%, barplot in Fig.Â <xref ref-type="fig" rid="Fig3">3</xref>a), a picture that resembles previous studies [<xref ref-type="bibr" rid="CR45">45</xref>]. On the contrary, DMPs in Sotos were dominated by CpGs that decrease their methylation level in individuals with the syndrome (i.e., hypomethylated, 99.27%, barplot in Fig.Â <xref ref-type="fig" rid="Fig3">3</xref>a), consistent with previous reports [<xref ref-type="bibr" rid="CR44">44</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p>Comparison between the DNA methylation changes during physiological aging and in Sotos. <bold>a</bold> Left: barplot showing the total number of differentially methylated positions (DMPs) found during physiological aging and in Sotos syndrome. CpG sites that increase their methylation levels with age in our healthy population or those that are elevated in Sotos patients (when compared with a control) are displayed in red. Conversely, those CpG sites that decrease their methylation levels are displayed in blue. Right: a table that represents the intersection between the aging (aDMPs) and the Sotos DMPs. The subset resulting from the intersection between the hypomethylated DMPs in aging and Sotos is called the âHypo-Hypo DMPsâ subset (<italic>N</italic>â=â1728). <bold>b</bold> Enrichment for the categorical (epi) genomic features considered when comparing the different genome-wide subsets of differentially methylated positions (DMPs) in aging and Sotos against a control (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section). The <italic>y</italic>-axis represents the odds ratio (OR), the error bars show the 95% confidence interval for the OR estimate and the color of the points codes for -log<sub>10</sub>(<italic>p</italic> value) obtained after testing for enrichment using Fisherâs exact test. An ORâ&gt;â1 shows that the given feature is enriched in the subset of DMPs considered, whilst an ORâ&lt;â1 shows that it is found less than expected. In gray: features that did not reach significance using a significance level of <italic>Î±</italic>â=â0.01 after Bonferroni correction. <bold>c</bold> Boxplots showing the distributions of the ânormalised RNA expressionâ (NRE) when comparing the different genome-wide subsets of differentially methylated positions (DMPs) in aging and Sotos against a control (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section). NRE represents normalized mean transcript abundance in a window of Â±â200âbp from the CpG site coordinate (DMP) being considered (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section). The <italic>p</italic> values (two-sided Wilcoxonâs test, before multiple testing correction) are shown above the boxplots. The number of DMPs belonging to each subset (in green) and the median value of the feature score (in dark red) are shown below the boxplots. <bold>d</bold> Same as <bold>c</bold>, but showing the ânormalised fold changeâ (NFC) for the H3K36me3 histone modification (representing normalized mean ChIP-seq fold change for H3K36me3 in a window of Â±â200âbp from the DMP being considered, see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section)</p></caption><graphic id="MO3" xlink:href="13059_2019_1753_Fig3_HTML"></graphic></fig></p>
<p id="Par38">Then, we compared the intersections between the hypermethylated and hypomethylated DMPs in aging and Sotos. Most of the DMPs were specific for aging or Sotos (i.e., they did not overlap), but a subset of them was shared (table in Fig.Â <xref ref-type="fig" rid="Fig3">3</xref>a). Interestingly, there were 1728 DMPs that became hypomethylated both during aging and in Sotos (Hypo-Hypo DMPs). This subset of DMPs is of special interest because it could be used to understand in more depth some of the mechanisms that drive hypomethylation during physiological aging. Thus, we tested whether the different subsets of DMPs are found in specific genomic contexts (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3A,B). DMPs that are hypomethylated during aging and in Sotos were both enriched (odds ratio &gt;â1) in enhancer categories (such as âactive enhancer 1â or âweak enhancer 1â, see the chromatin state model used, from the K562 cell line, in the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section) and depleted (odds ratio &lt;â1) for active transcription categories (such as âactive TSSâ or âstrong transcriptionâ), which was also observed in the âHypo-Hypo DMPsâ subset (Fig.Â <xref ref-type="fig" rid="Fig3">3</xref>b). Interestingly, age-related hypomethylation in enhancers seems to be a characteristic of both humans [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>] and mice [<xref ref-type="bibr" rid="CR25">25</xref>]. Furthermore, both de novo DNA methyltransferases (DNMT3A and DNMT3B) have been shown to bind in an H3K36me3-dependent manner to active enhancers [<xref ref-type="bibr" rid="CR48">48</xref>], consistent with our results.</p>
<p id="Par39">When looking at the levels of total RNA expression (depleted for rRNA) in the blood, we confirmed a significant reduction in the RNA levels around these hypomethylated DMPs when compared with the control sets (Fig.Â <xref ref-type="fig" rid="Fig3">3</xref>c, see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section for more details on how the control sets were defined). Interestingly, hypomethylated DMPs in both aging and Sotos were depleted from the gene bodies (Fig.Â <xref ref-type="fig" rid="Fig3">3</xref>b) and were located in areas with lower levels of H3K36me3 when compared with the control sets (Fig.Â <xref ref-type="fig" rid="Fig3">3</xref>d, see AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3B for a comprehensive comparison of all the DMPs subsets). Moreover, hypomethylated aDMPs and hypomethylated Sotos DMPs were both generally enriched or depleted for the same histone marks in the blood (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3B), which adds weight to the hypothesis that they share the same genomic context and could become hypomethylated through similar molecular mechanisms.</p>
<p id="Par40">Intriguingly, we also identified a subset of DMPs (2550) that were hypermethylated during aging and hypomethylated in Sotos (Fig.Â <xref ref-type="fig" rid="Fig3">3</xref>a). These âHyper-Hypo DMPsâ seem to be enriched for categories such as âbivalent promoterâ and ârepressed polycombâ (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3A), which are normally associated with developmental genes [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. These categories are also a defining characteristic of the hypermethylated aDMPs, highlighting that even though the direction of the DNA methylation changes is different in some aging and Sotos DMPs, the genomic context in which they happen is shared.</p>
<p id="Par41">Finally, we looked at the DNA methylation patterns in the 353 Horvathâs epigenetic clock CpG sites for the Sotos samples. For each clock CpG site, we modeled the changes of DNA methylation during the lifespan in the healthy control individuals and then calculated the deviations from these patterns for the Sotos samples (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3C, see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section). As expected, the landscape of clock CpG sites is dominated by hypomethylation in the Sotos samples, although only a small fraction of the clock CpG sites seem to be significantly affected (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3D, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM6">6</xref>). Overall, we confirmed the trends reported for the genome-wide analysis (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3E-G). However, given the much smaller number of CpG sites to consider in this analysis, very few comparisons reached significance.</p>
<p id="Par42">We have demonstrated that the aging process and Sotos syndrome share a subset of hypomethylated CpG sites that are characterized by an enrichment in enhancer features and a depletion of active transcription activity. This highlights the usefulness of developmental disorders as a model to study the mechanisms that may drive the changes in the methylome with age, since they permit stratification of the aging DMPs into different functional categories that are associated with alterations in the function of specific genes and hence specific molecular components of the epigenetic aging clock.</p>
</sec>
<sec id="Sec6">
<title>Sotos syndrome is associated with a decrease of methylation Shannon entropy in the epigenetic clock CpG sites</title>
<p id="Par43">Shannon entropy can be used in the context of DNA methylation analysis to estimate the information content stored in a given set of CpG sites. Shannon entropy is minimized when the methylation levels of all the CpG sites are either 0% or 100% and maximized when all of them are 50% (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section). Previous reports have shown that the Shannon entropy associated with the methylome increases with age, which implies that the epigenome loses information content [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. We confirmed this genome-wide effect (i.e., considering all the CpG sites that passed our pre-processing pipeline) in our healthy samples, where we observed a positive Spearman correlation coefficient between chronological age and genome-wide Shannon entropy of 0.3984 (<italic>p</italic> valueâ=â3.21âÃâ10<sup>â44</sup>). This result was robust when removing outlier batches (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4C). Next, we tested whether Sotos patients present genome-wide Shannon entropy acceleration, i.e., deviations from the expected genome-wide Shannon entropy for their age (see the â<xref ref-type="sec" rid="Sec9">Methods</xref>â section). Despite detailed analysis, we did not find evidence that this was the case when looking genome-wide (<italic>p</italic> valueâ=â0.71, Fig.Â <xref ref-type="fig" rid="Fig4">4</xref>a, b; AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4A). This conclusion held when the comparison was performed inside the batch that contained the Sotos samples (GSE74432), therefore providing evidence that it is not confounded by batch effect (<italic>p</italic> valueâ=â0.73, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4E).<fig id="Fig4"><label>Fig. 4</label><caption><p>Analysis of methylation Shannon entropy during physiological aging and in Sotos syndrome. <bold>a</bold> Scatterplot showing the relation between genome-wide Shannon entropy (i.e., calculated using the methylation levels of all the CpG sites in the array) and chronological age of the samples for Sotos (orange) and healthy controls (gray). Each sample is represented by one point. <bold>b</bold> Boxplots showing the distributions of genome-wide Shannon entropy acceleration (i.e., deviations from the expected genome-wide Shannon entropy for their age) for the control and Sotos samples. The <italic>p</italic> value displayed on top of the boxplots was derived from a two-sided Wilcoxonâs test. <bold>c</bold> Same as <bold>a</bold>., but using the Shannon entropy calculated only for the 353 CpG sites in the Horvath epigenetic clock. <bold>d</bold> Same as <bold>b</bold>, but using the Shannon entropy calculated only for the 353 CpG sites in the Horvath epigenetic clock</p></caption><graphic id="MO4" xlink:href="13059_2019_1753_Fig4_HTML"></graphic></fig></p>
<p id="Par44">When we considered only the 353 clock CpG sites for the entropy calculations, the picture was different. Shannon entropy for the 353 clock sites slightly decreased with age in the controls when we included all the batches, showing the opposite direction when compared with the genome-wide entropy (Spearman correlation coefficientâ=âââ0.1223, <italic>p</italic> valueâ=â3.8166âÃâ10<sup>â5</sup>, Fig.Â <xref ref-type="fig" rid="Fig4">4</xref>c). However, when we removed the âEuropeâ batch (which was an outlier even after pre-processing, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4D), this trend was reversed and we observed a weak increase of clock Shannon entropy with age (Spearman correlation coefficientâ=â0.1048, <italic>p</italic> valueâ=â8.6245âÃâ10<sup>â5</sup>). This shows that Shannon entropy calculations are very sensitive to batch effects, especially when considering a small number of CpG sites, and the results must be interpreted carefully.</p>
<p id="Par45">Interestingly, the mean Shannon entropy across all the control samples was higher in the epigenetic clock sites (meanâ=â0.4726, Fig.Â <xref ref-type="fig" rid="Fig4">4</xref>c) with respect to the genome-wide entropy (meanâ=â0.3913, Fig.Â <xref ref-type="fig" rid="Fig4">4</xref>a). Sotos syndrome patients displayed a lower clock Shannon entropy when compared with the control (<italic>p</italic> valueâ=â5.0449âÃâ10<sup>â12</sup>, Fig.Â <xref ref-type="fig" rid="Fig4">4</xref>d, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4B), which is probably driven by the hypomethylation of the clock CpG sites. Importantly, this conclusion held when the comparison was performed inside the batch that contained the Sotos samples (GSE74432), again providing evidence that it is not confounded by batch effect (<italic>p</italic> valueâ=â7.3757âÃâ10<sup>â11</sup>, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4F). Furthermore, this highlights that the Horvath clock sites could have slightly different characteristics in terms of the methylation entropy associated with them when compared with the genome as a whole, something that to our knowledge has not been reported before.</p>
</sec>
</sec>
<sec id="Sec7">
<title>Discussion</title>
<p id="Par46">The epigenetic aging clock has emerged as the most accurate biomarker of the aging process, and it seems to be a conserved property in mammalian genomes [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. However, we do not know yet whether the age-related DNA methylation changes measured are functional at all or whether they are related to some fundamental process of the biology of aging. Developmental disorders in humans represent an interesting framework to look at the biological effects of mutations in genes that are fundamental for the integrity of the epigenetic landscape and other core processes, such as growth or neurodevelopment [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Furthermore, according to the <italic>epigenetic clock theory of aging</italic>, epigenetic clocks provide a continuous readout that connects purposeful processes in development with adverse effects in later life [<xref ref-type="bibr" rid="CR5">5</xref>]. Therefore, using a reverse genetics approach, we aimed to identify the genes that disrupt the aspects of the behavior of the epigenetic aging clock in humans.</p>
<p id="Par47">Most of the studies have looked at the epigenetic aging clock using Horvathâs model [<xref ref-type="bibr" rid="CR8">8</xref>], which has a ready-to-use online calculator for epigenetic age [<xref ref-type="bibr" rid="CR51">51</xref>]. This has clearly simplified the computational process and helped a lot of research groups to test the behavior of the epigenetic clock in their system of interest. However, this has also led to the treatment of the epigenetic clock as a âblack-boxâ, without a critical assessment of the statistical methodology behind it. Therefore, we decided to benchmark the main steps involved when estimating epigenetic age acceleration (pre-processing of the raw data from methylation arrays and cell composition deconvolution algorithms), to quantify the effects of technical variation on the epigenetic clock predictions and to assess the impact of the control age distribution on the epigenetic age acceleration calculations. Previous attempts to account for technical variation have used the first 5 principal components (PCs) estimated directly from the DNA methylation data [<xref ref-type="bibr" rid="CR23">23</xref>]. However, this approach potentially removes meaningful biological variation. For the first time, we have shown that it is possible to use the control probes from the 450K array to readily correct for batch effects in the context of the epigenetic clock, which reduces the error associated with the predictions and decreases the likelihood of reporting a false positive. Furthermore, we have confirmed the suspicion that Horvathâs model underestimates epigenetic age for older ages [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>] and assessed the impact of this bias in the screen for epigenetic age acceleration.</p>
<p id="Par48">The results from our screen strongly suggest that Sotos syndrome accelerates epigenetic aging, and this effect was confirmed using other epigenetic clocks. Sotos syndrome is caused by loss-of-function mutations in the <italic>NSD1</italic> gene [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>], which encodes a histone H3 lysine 36 (H3K36) methyltransferase. This leads to a phenotype which can include prenatal and postnatal overgrowth, facial gestalt, advanced bone age, developmental delay, higher cancer predisposition, and, in some cases, heart defects [<xref ref-type="bibr" rid="CR42">42</xref>]. Remarkably, many of these characteristics could be interpreted as aging-like, identifying Sotos syndrome as a potential human model of accelerated physiological aging.</p>
<p id="Par49">NSD1 catalyzes the addition of either monomethyl (H3K36me) or dimethyl groups (H3K36me2) and indirectly regulates the levels of trimethylation (H3K36me3) by altering the availability of the monomethyl and dimethyl substrates for the trimethylation enzymes (SETD2 in humans, whose mutations cause a âSotos-likeâ overgrowth syndrome) [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. H3K36 methylation has a complex role in the regulation of transcription [<xref ref-type="bibr" rid="CR52">52</xref>] and has been shown to regulate nutrient stress response in yeast [<xref ref-type="bibr" rid="CR54">54</xref>]. Moreover, experiments in model organisms (yeast and worm) have demonstrated that mutations in H3K36 methyltranferases decrease lifespan, and remarkably, mutations in H3K36 demethylases increase it [<xref ref-type="bibr" rid="CR55">55</xref>â<xref ref-type="bibr" rid="CR57">57</xref>].</p>
<p id="Par50">In humans, DNA methylation patterns are established and maintained by three conserved enzymes: the maintenance DNA methyltransferase DNMT1 and the de novo DNA methyltransferases DNMT3A and DNMT3B [<xref ref-type="bibr" rid="CR58">58</xref>]. Both DNMT3A and DNMT3B contain PWWP domains that can read the H3K36me3 histone mark [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Therefore, the H3K36 methylation landscape can influence DNA methylation levels in specific genomic regions through the recruitment of the de novo DNA methyltransferases. Mutations in the PWWP domain of DNMT3A impair its binding to H3K36me2 and H3K36me3 and cause an undergrowth disorder in humans (microcephalic dwarfism) [<xref ref-type="bibr" rid="CR61">61</xref>]. This redirects DNMT3A, which is normally targeted to H3K36me2 and H3K36me3 throughout the genome, to DNA methylation valleys (DMVs, aka DNA methylation canyons), which become hypermethylated [<xref ref-type="bibr" rid="CR61">61</xref>], a phenomenon that also seems to happen during physiological aging in humans [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>] and mice [<xref ref-type="bibr" rid="CR25">25</xref>]. DMVs are hypomethylated domains conserved across cell types and species, often associated with Polycomb-regulated developmental genes and marked by bivalent chromatin (with H3K27me3 and H3K4me3) [<xref ref-type="bibr" rid="CR64">64</xref>â<xref ref-type="bibr" rid="CR67">67</xref>]. Therefore, we suggest a model (Fig.Â <xref ref-type="fig" rid="Fig5">5</xref>) where the reduction in the levels of H3K36me2 and/or H3K36me3, caused by a proposed decrease in H3K36 methylation maintenance during aging or NSD1 function in Sotos syndrome, could lead to hypomethylation in many genomic regions (because DNMT3A is recruited less efficiently) and hypermethylation in DMVs (because of the higher availability of DNMT3A). Indeed, we observe enrichment for categories such as âbivalent promoterâ or ârepressed polycombâ in the hypermethylated DMPs in Sotos and aging (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3A), which is also supported by higher levels of polycomb repressing complex 2 (PRC2, represented by EZH2) and H3K27me3, the mark deposited by PRC2 (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3B). This is also consistent with the results obtained for the epigenetic mitotic clock [<xref ref-type="bibr" rid="CR39">39</xref>], where we observe a trend towards increased hypermethylation of Polycomb-bound regions in Sotos patients. Furthermore, it is worth mentioning that a mechanistic link between PRC2 recruitment and H3K36me3 has also been unravelled to occur via the Tudor domains of some polycomb-like proteins [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>].<fig id="Fig5"><label>Fig. 5</label><caption><p>Proposed model that highlights the role of H3K36 methylation maintenance on epigenetic aging. The H3K36me2/3 mark allows recruiting de novo DNA methyltransferases DNMT3A (in green) and DNMT3B (not shown) through their PWWP domain (in blue) to different genomic regions (such as gene bodies or pericentric heterochromatin) [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>], which leads to the methylation of the cytosines in the DNA of these regions (5-mC, black lollipops). On the contrary, DNA methylation valleys (DMVs) are conserved genomic regions that are normally found hypomethylated and associated with Polycomb-regulated developmental genes [<xref ref-type="bibr" rid="CR64">64</xref>â<xref ref-type="bibr" rid="CR67">67</xref>]. During aging, the H3K36 methylation machinery could become less efficient at maintaining the H3K36me2/3 landscape. This would lead to a relocation of de novo DNA methyltransferases from their original genomic reservoirs (which would become hypomethylated) to other non-specific regions such as DMVs (which would become hypermethylated and potentially lose their normal boundaries), with functional consequences for the tissues. This is also partially observed in patients with Sotos syndrome, where mutations in NSD1 potentially affect H3K36me2/3 patterns and accelerate the epigenetic aging clock as measured with the Horvath model [<xref ref-type="bibr" rid="CR8">8</xref>]. Given that DNMT3B is enriched in the gene bodies of highly transcribed genes [<xref ref-type="bibr" rid="CR60">60</xref>] and that we found these regions depleted in our differential methylation analysis, we hypothesize that the hypermethylation of DMVs could be mainly driven by DNMT3A instead. However, it is important to mention that our analysis does not discard a role of DNMT3B during epigenetic aging</p></caption><graphic id="MO5" xlink:href="13059_2019_1753_Fig5_HTML"></graphic></fig></p>
<p id="Par51">A recent preprint has shown that loss-of-function mutations in DNMT3A, which cause Tatton-Brown-Rahman overgrowth syndrome, also lead to a higher ticking rate of the epigenetic aging clock [<xref ref-type="bibr" rid="CR72">72</xref>]. They also report positive epigenetic age acceleration in Sotos syndrome and negative acceleration in Kabuki syndrome, consistent with our results. Furthermore, they observe a DNA methylation signature in the DNMT3A mutants characterized by widespread hypomethylation, with a modest enrichment of DMPs in the regions upstream of the transcription start site, shores, and enhancers [<xref ref-type="bibr" rid="CR72">72</xref>], which we also detect in our âHypo-Hypo DMPsâ (those that become hypomethylated both during physiological aging and in Sotos). Therefore, the hypomethylation observed in our âHypo-Hypo DMPsâ is consistent with a reduced methylation activity of DNMT3A, which in our system could be a consequence of the decreased recruitment of DNMT3A to genomic regions that have lost H3K36 methylation (Fig.Â <xref ref-type="fig" rid="Fig5">5</xref>).</p>
<p id="Par52">Interestingly, H3K36me3 is required for the selective binding of the de novo DNA methyltransferase DNMT3B to the bodies of highly transcribed genes [<xref ref-type="bibr" rid="CR60">60</xref>]. Furthermore, DNMT3B loss reduces gene body methylation, which leads to intragenic spurious transcription (aka cryptic transcription) [<xref ref-type="bibr" rid="CR73">73</xref>]. An increase in this so-called cryptic transcription seems to be a conserved feature of the aging process [<xref ref-type="bibr" rid="CR56">56</xref>]. Therefore, the changes observed in the âHypo-Hypo DMPsâ could theoretically be a consequence of the loss of H3K36me3 and the concomitant inability of DNMT3B to be recruited to gene bodies. However, the âHypo-Hypo DMPsâ were depleted for H3K36me3, active transcription, and gene bodies when compared with the rest of the probes in the array (Fig.Â <xref ref-type="fig" rid="Fig3">3</xref>bâd), prompting us to suggest that the DNA methylation changes observed are likely mediated by DNMT3A instead (Fig.Â <xref ref-type="fig" rid="Fig5">5</xref>). Nevertheless, it is worth mentioning that the different biological replicates for the blood H3K36me3 ChIP-seq datasets were quite heterogeneous and that the absolute difference in the case of the hypomethylated Sotos DMPs, although significant due to the big sample sizes, is quite small. Thus, we cannot exclude the existence of this mechanism during human aging, and an exhaustive study on the prevalence of cryptic transcription in humans and its relation to the aging methylome should be carried out.</p>
<p id="Par53">H3K36me3 has also been shown to guide deposition of the N6-methyladenosine mRNA modification (m<sup>6</sup>A), an important post-transcriptional mechanism of gene regulation [<xref ref-type="bibr" rid="CR74">74</xref>]. Interestingly, a decrease in overall m<sup>6</sup>A during human aging has been previously reported in PBMC [<xref ref-type="bibr" rid="CR75">75</xref>], suggesting another biological route through which an alteration of the H3K36 methylation landscape could have functional consequences for the organism.</p>
<p id="Par54">Because of the way that the Horvath epigenetic clock was trained [<xref ref-type="bibr" rid="CR8">8</xref>], it is likely that its constituent 353 CpG sites are a low-dimensional representation of the different genome-wide processes that are eroding the epigenome with age. Our analysis has shown that these 353 CpG sites are characterized by a higher Shannon entropy when compared with the rest of the genome, which is dramatically decreased in the case of Sotos patients. This could be related to the fact that the clock CpGs are enriched in the regions of bivalent chromatin (marked by H3K27me3 and H3K4me3), conferring a more dynamic or plastic regulatory state with levels of DNA methylation deviated from the collapsed states of 0 or 1. Interestingly, EZH2 (part of polycomb repressing complex 2, responsible for H3K27 methylation) is an interacting partner of DNMT3A and NSD1, with mutations in NSD1 affecting the genome-wide levels of H3K27me3 [<xref ref-type="bibr" rid="CR76">76</xref>]. Furthermore, Kabuki syndrome was weakly identified in our screen as having an epigenome younger than expected, which could be related to the fact that they show postnatal dwarfism [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. Kabuki syndrome is caused by loss-of-function mutations in KMT2D [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>], a major mammalian H3K4 mono-methyltransferase [<xref ref-type="bibr" rid="CR79">79</xref>]. Additionally, H3K27me3 and H3K4me3 levels can affect lifespan in model organisms [<xref ref-type="bibr" rid="CR3">3</xref>]. It will be interesting to test whether bivalent chromatin is a general feature of multi-tissue epigenetic aging clocks.</p>
<p id="Par55">Thus, DNMT3A, NSD1, and the machinery in control of bivalent chromatin (such as EZH2 and KMT2D) contribute to an emerging picture on how the mammalian epigenome is regulated during aging, which could open new avenues for anti-aging drug development. Mutations in these proteins lead to different developmental disorders with impaired growth defects [<xref ref-type="bibr" rid="CR30">30</xref>], with DNMT3A, NSD1, and potentially KMT2D also affecting epigenetic aging. Interestingly, EZH2 mutations (which cause Weaver syndrome, TableÂ <xref ref-type="table" rid="Tab1">1</xref>) do not seem to affect the epigenetic clock in our screen. However, this syndrome has the smallest number of samples (7), and this could limit the power to detect any changes.</p>
<p id="Par56">Our screen has also revealed that Rett syndrome and fragile X syndrome (FXS) could potentially have an accelerated epigenetic age. It is worth noting that FXS is caused by an expansion of the CGG trinucleotide repeat located in the 5â² UTR of the <italic>FMR1</italic> gene [<xref ref-type="bibr" rid="CR80">80</xref>]. Interestingly, Huntingtonâs disease, caused by a trinucleotide repeat expansion of CAG, has also been shown to accelerate epigenetic aging of the human brain [<xref ref-type="bibr" rid="CR23">23</xref>], pointing towards trinucleotide repeat instability as an interesting molecular mechanism to look at from an aging perspective. It is important to notice that the conclusions for Rett syndrome, FXS, and Kabuki syndrome were very dependent on the age range used in the healthy control (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2A), and these results must therefore be treated with caution.</p>
<p id="Par57">Our study has several limitations that we tried to address in the best possible way. First of all, given that DNA methylation data for patients with developmental disorders is relatively rare, some of the sample sizes were quite small. It is thus possible that some of the other developmental disorders assessed are epigenetically accelerated but we lack the power to detect this. Furthermore, individuals with the disorders tend to get sampled when they are young, i.e., before reproductive age. Horvathâs clock adjusts for the different rates of change in the DNA methylation levels of the clock CpGs before and after reproductive age (20âyears in humans) [<xref ref-type="bibr" rid="CR8">8</xref>], but this could still have an effect on the predictions, especially if the control is not properly age-matched. Our solution was to discard those developmental disorders with less than 5 samples, and we required them to have at least 2 samples with an age â¥â20âyears, which reduced the list of final disorders included to the ones listed in TableÂ <xref ref-type="table" rid="Tab1">1</xref>.</p>
<p id="Par58">Future studies should increase the sample size and follow the patients during their entire lifespan in order to confirm our findings. Directly measuring the functional changes in the H3K36 methylation landscape (or its machinery) during human aging will further validate this work. Moreover, it would be interesting to identify mutations that affect, besides the mean, the variance of epigenetic age acceleration, since changes in methylation variability at single CpG sites with age have been associated with fundamental aging mechanisms [<xref ref-type="bibr" rid="CR46">46</xref>]. Finally, testing the influence of H3K36 methylation on the epigenetic clock and lifespan in mice will provide deeper mechanistic insights.</p>
</sec>
<sec id="Sec8">
<title>Conclusions</title>
<p id="Par59">The epigenetic aging clock has created a new methodological paradigm to study the aging process in humans. However, the molecular mechanisms that control its ticking rate are still mysterious. In this study, by looking at patients with developmental disorders, we have demonstrated that Sotos syndrome accelerates epigenetic aging and uncovered a potential role of the H3K36 methylation machinery as a key component of the <italic>epigenetic maintenance system</italic> in humans. We hope that this research will shed some light on the different processes that erode the human epigenetic landscape during aging and provide a new hypothesis about the mechanisms behind the epigenetic aging clock.</p>
</sec>
<sec id="Sec9">
<title>Methods</title>
<sec id="Sec10">
<title>Sample collection and annotation</title>
<p id="Par60">We collected DNA methylation data generated with the Illumina Infinium HumanMethylation450 BeadChip (450K array) from human blood. In the case of the developmental disorder samples, we combined public data with the data generated in-house for other clinical studies (TableÂ <xref ref-type="table" rid="Tab1">1</xref>, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM2">2</xref>) [<xref ref-type="bibr" rid="CR31">31</xref>]. We took all the data for developmental disorders that we could find in order to perform unbiased screening. The healthy samples used to build the control were mainly obtained from public sources (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM3">3</xref>). Basic metadata (including the chronological age) was also stored. All the mutations in the developmental disorder samples were manually curated using Variant Effect Predictor [<xref ref-type="bibr" rid="CR81">81</xref>] in the GRCh37 (hg19) human genome assembly. Those samples with a variant of unknown significance that had the characteristic DNA methylation signature of the disease were also included (they are labelled as âYES_predictedâ in AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM2">2</xref>). In the case of fragile X syndrome (FXS), only male samples with full mutation (&gt;â200 repeats) [<xref ref-type="bibr" rid="CR80">80</xref>] were included in the final screen. As a consequence, only the samples with a clear molecular and clinical diagnosis were kept for the final screen.</p>
</sec>
<sec id="Sec11">
<title>Pre-processing, QC, and filtering the data for the epigenetic clock calculations</title>
<p id="Par61">Raw DNA methylation array data (IDAT files) were processed using the <italic>minfi</italic> R package [<xref ref-type="bibr" rid="CR82">82</xref>]. Raw data were background-corrected using <italic>noob</italic> [<xref ref-type="bibr" rid="CR83">83</xref>] before calculating the beta values. In the case of the beta values which are input to Horvathâs model, we observed that background correction did not have a major impact in the final predictions of epigenetic age acceleration in the control as long as we corrected for batch effects (Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>c, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5A). We decided to keep the <italic>noob</italic> background correction step for consistency with the rest of the pipelines. Epigenetic age (<italic>DNAmAge</italic>) was calculated using the code from Horvath, which includes an internal normalization step against a blood gold standard [<xref ref-type="bibr" rid="CR8">8</xref>]. The scripts are available in our GitHub repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/demh/epigenetic_ageing_clock">https://github.com/demh/epigenetic_ageing_clock</ext-link>) for the use of the community [<xref ref-type="bibr" rid="CR84">84</xref>].</p>
<p id="Par62">Quality control (QC) was performed in all samples. Following the guidelines from the <italic>minfi</italic> package [<xref ref-type="bibr" rid="CR82">82</xref>], only those samples that satisfied the following criteria were kept for the analysis: the sex predicted from the DNA methylation data was the same as the reported sex in the metadata, they passed BMIQ normalization and <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \frac{\mathrm{median}\left({\log}_2M\right)+\mathrm{median}\left({\log}_2U\right)}{2}\ge 10.5 $$\end{document}</tex-math><mml:math display="inline" id="M2"><mml:mfrac><mml:mrow><mml:mtext>median</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mo>log</mml:mo><mml:mn>2</mml:mn></mml:msub><mml:mi>M</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mtext>median</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mo>log</mml:mo><mml:mn>2</mml:mn></mml:msub><mml:mi>U</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:mfrac><mml:mo>â¥</mml:mo><mml:mn>10.5</mml:mn></mml:math><inline-graphic xlink:href="13059_2019_1753_Article_IEq1.gif"></inline-graphic></alternatives></inline-formula>, where <italic>M</italic> is the methylated intensity and <italic>U</italic> the unmethylated intensity for the array probes.</p>
</sec>
<sec id="Sec12">
<title>Correcting for batch effects</title>
<p id="Par63">In order to correct for batch effects that could confound the conclusions from our analysis, we decided to make use of the control probes available in the 450K array. These probes capture only the technical variance in negative controls and different steps of the array protocol, such as bisulfite conversion, staining or hybridization [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]. We performed PCA (with centering but not scaling using the <italic>prcomp</italic> function in R) on the raw intensities of the control probes (847 probesâÃâ2 channelsâ=â1694 intensity values) for all our controls (<italic>N</italic>â=â2218) and cases (<italic>N</italic>â=â666) that passed QC (Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>a). Including the technical PCs as covariates in the models to calculate epigenetic age acceleration (EAA) improved the error from the predictions in the controls (Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>c, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5A). The optimal number of PCs was found by making use of the <italic>findElbow</italic> function from [<xref ref-type="bibr" rid="CR86">86</xref>].</p>
</sec>
<sec id="Sec13">
<title>Correcting for cell composition</title>
<p id="Par64">The proportions of different blood cell types change with age and this can affect the methylation profiles of the samples. Therefore, when calculating the epigenetic age acceleration, it is important to compare the models with and without cell type proportions included as covariates [<xref ref-type="bibr" rid="CR38">38</xref>]. Cell type proportions can be estimated from DNA methylation data using different deconvolution algorithms [<xref ref-type="bibr" rid="CR87">87</xref>]. In the context of the epigenetic clock, most of the studies have used the Houseman method [<xref ref-type="bibr" rid="CR88">88</xref>]. We have benchmarked different reference-based deconvolution strategies (combining different pre-processing steps, references, and deconvolution algorithms) against a gold standard dataset (GSE77797) [<xref ref-type="bibr" rid="CR89">89</xref>]. Our results suggest that using the IDOL strategy [<xref ref-type="bibr" rid="CR89">89</xref>] to build the blood reference (from the Reinius et al. dataset, GSE35069) [<xref ref-type="bibr" rid="CR90">90</xref>], together with the Houseman algorithm [<xref ref-type="bibr" rid="CR88">88</xref>] and some pre-processing steps (<italic>noob</italic> background correction, probe filtering, BMIQ normalization), leads to the best cell type proportions estimates, i.e., those that minimize the deviations between our estimates and the real cell type composition of the samples in the gold standard dataset (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5B, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM4">4</xref>). We used the <italic>epidish</italic> function from the <italic>EpiDISH</italic> R package [<xref ref-type="bibr" rid="CR91">91</xref>] for these purposes.</p>
</sec>
<sec id="Sec14">
<title>Calculating the epigenetic age acceleration and performing the main screen</title>
<p id="Par65">Only those developmental disorders for which we had at least 5 samples, with 2 of them with an age â¥â20âyears, were included in the main screen (<italic>N</italic>â=â367). Healthy samples that matched the age range of those disorders (0â55âyears, <italic>N</italic>â=â1128) were used to train the following linear models (the <italic>control models</italic>):<list list-type="simple"><list-item><label>(I)</label><p id="Par66">Without cell composition correction (CCC):</p></list-item></list></p>
<p id="Par67">
<disp-formula id="Equa"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{DNAmAge}\sim \mathrm{Age}+\mathrm{Sex}+\mathrm{PC}1+\mathrm{PC}2+\dots +\mathrm{PC}\mathrm{N} $$\end{document}</tex-math><mml:math display="block" id="M4"><mml:mtext>DNAmAge</mml:mtext><mml:mo>~</mml:mo><mml:mi>Age</mml:mi><mml:mo>+</mml:mo><mml:mi>Sex</mml:mi><mml:mo>+</mml:mo><mml:mtext>PC1</mml:mtext><mml:mo>+</mml:mo><mml:mtext>PC2</mml:mtext><mml:mo>+</mml:mo><mml:mo>â¦</mml:mo><mml:mo>+</mml:mo><mml:mi>PCN</mml:mi></mml:math><graphic position="anchor" xlink:href="13059_2019_1753_Article_Equa.gif"></graphic></alternatives></disp-formula>
<list list-type="simple"><list-item><label>(II)</label><p id="Par68">With cell composition correction (CCC):</p></list-item></list>
</p>
<p id="Par69">
<disp-formula id="Equb"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{DNAmAge}\sim \mathrm{Age}+\mathrm{Sex}+\mathrm{Gran}+\mathrm{CD}4\mathrm{T}+\mathrm{CD}8\mathrm{T}+\mathrm{B}+\mathrm{Mono}+\mathrm{NK}+\mathrm{PC}1+\mathrm{PC}2+\dots +\mathrm{PC}\mathrm{N} $$\end{document}</tex-math><mml:math display="block" id="M6"><mml:mtext>DNAmAge</mml:mtext><mml:mo>~</mml:mo><mml:mi>Age</mml:mi><mml:mo>+</mml:mo><mml:mi>Sex</mml:mi><mml:mo>+</mml:mo><mml:mtext>Gran</mml:mtext><mml:mo>+</mml:mo><mml:mi>CD</mml:mi><mml:mn>4</mml:mn><mml:mi mathvariant="normal">T</mml:mi><mml:mo>+</mml:mo><mml:mi>CD</mml:mi><mml:mn>8</mml:mn><mml:mi mathvariant="normal">T</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">B</mml:mi><mml:mo>+</mml:mo><mml:mtext>Mono</mml:mtext><mml:mo>+</mml:mo><mml:mi>NK</mml:mi><mml:mo>+</mml:mo><mml:mtext>PC1</mml:mtext><mml:mo>+</mml:mo><mml:mtext>PC2</mml:mtext><mml:mo>+</mml:mo><mml:mo>â¦</mml:mo><mml:mo>+</mml:mo><mml:mi>PCN</mml:mi></mml:math><graphic position="anchor" xlink:href="13059_2019_1753_Article_Equb.gif"></graphic></alternatives></disp-formula>
</p>
<p id="Par70">where <italic>DNAmAge</italic> is the epigenetic age calculated using Horvathâs model [<xref ref-type="bibr" rid="CR8">8</xref>], <italic>Age</italic> is the chronological age, <italic>PCN</italic> is the <italic>N</italic>th technical PC obtained from the control probes (<italic>N</italic>â=â17 was the optimal, Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>c) and <italic>Gran</italic>, <italic>CD4T</italic>, <italic>CD8T</italic>, <italic>B</italic>, <italic>Mono</italic>, and <italic>NK</italic> are the different proportions of the blood cell types as estimated with our deconvolution strategy. The linear models were fitted in R with the <italic>lm</italic> function, which uses least-squares.</p>
<p id="Par71">The residuals from a control model represent the epigenetic age acceleration (EAA) for the different healthy samples, which should be centered around zero after batch effect correction (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1E, Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>d). Then, the median absolute error (MAE) can be calculated as (Fig.Â <xref ref-type="fig" rid="Fig1">1</xref>c, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S5A):<list list-type="simple"><list-item><label>(III)</label><p id="Par72"> MAEâ= median(<italic>abs</italic>(EAA<italic>i</italic>))</p></list-item></list>where EAA<sub><italic>i</italic></sub> is the epigenetic age acceleration for a healthy sample from the control.</p>
<p id="Par73">Once the control models are established, we can calculate the EAA for the different samples with a developmental disorder (cases) by taking the difference between the epigenetic age (<italic>DNAmAge</italic>) for the case sample and the predicted value from the corresponding control model (with or without cell composition correction). Finally, the distributions of the EAA for the different developmental disorders were compared against the EAA distribution for the healthy controls using a two-sided Wilcoxonâs test. <italic>p</italic> values were adjusted for multiple testing using Bonferroni correction and a significance level of <italic>Î±</italic>â=â0.01 was applied.</p>
<p id="Par74">A similar approach was used in the case of the other epigenetic clocks assessed. The linear coefficients for the different probes were obtained from the original publications [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. In the case of the skin-blood clock, the same age transformation employed for the Horvathâs clock was applied [<xref ref-type="bibr" rid="CR41">41</xref>]. Due to our filtering criteria, some array probes were missing, which could slightly affect the predictions of the different epigenetic clocks: Hannumâs clock [<xref ref-type="bibr" rid="CR9">9</xref>] (68/71 probes available), Linâs clock [<xref ref-type="bibr" rid="CR40">40</xref>] (97/99 probes available), and the skin-blood clock [<xref ref-type="bibr" rid="CR41">41</xref>] (385/391 probes available). This may be the reason behind the offset observed, particularly prominent in the predictions of Linâs clock (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S2C-E). Nevertheless, this bias is present in both Sotos and control samples, and therefore, it is unlikely that it affects the main conclusions.</p>
</sec>
<sec id="Sec15">
<title>Calculating <italic>pcgtAge</italic> and Shannon entropy</title>
<p id="Par75">Raw DNA methylation data (IDAT files) was background-corrected using <italic>noob</italic> [<xref ref-type="bibr" rid="CR83">83</xref>]. Next, we filtered out the probes associated with SNPs, cross-reactive probes [<xref ref-type="bibr" rid="CR92">92</xref>], and probes from the sex chromosomes, before performing BMIQ intra-array normalization to correct for the bias in probe design [<xref ref-type="bibr" rid="CR93">93</xref>]. Then, we calculated <italic>pcgtAge</italic> as the average of the beta values for the probes that constitute the epigenetic mitotic clock [<xref ref-type="bibr" rid="CR39">39</xref>]. It is worth noting that only 378 out of the 385 probes were left after our filtering criteria.</p>
<p id="Par76">Shannon entropy was calculated as previously described [<xref ref-type="bibr" rid="CR9">9</xref>]:<list list-type="simple"><list-item><label>(IV)</label><p id="Par77"><inline-formula id="IEq2"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{Entropy}=\frac{1}{N\times {\log}_2\left(\frac{1}{2}\right)}\times {\sum}_{i=1}^N\left[{\beta}_i\times {\log}_2\left({\beta}_i\right)+\left(1-{\beta}_i\right)\times {\log}_2\left(1-{\beta}_i\right)\right] $$\end{document}</tex-math><mml:math display="inline" id="M8"><mml:mtext>Entropy</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>N</mml:mi><mml:mo>Ã</mml:mo><mml:msub><mml:mo>log</mml:mo><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mfrac><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>Ã</mml:mo><mml:msubsup><mml:mo>â</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:msubsup><mml:mfenced close="]" open="["><mml:mrow><mml:msub><mml:mi>Î²</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>Ã</mml:mo><mml:msub><mml:mo>log</mml:mo><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>Î²</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>â</mml:mo><mml:msub><mml:mi>Î²</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>Ã</mml:mo><mml:msub><mml:mo>log</mml:mo><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>â</mml:mo><mml:msub><mml:mi>Î²</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="13059_2019_1753_Article_IEq2.gif"></inline-graphic></alternatives></inline-formula></p></list-item></list></p>
<p id="Par78">where <italic>Î²</italic><sub><italic>i</italic></sub> represents the methylation beta value for the <italic>i</italic>th probe (CpG site) in the array, <italic>N</italic>â=â428,266 for the genome-wide entropy, and <italic>N</italic>â=â353 for Horvath clock sites entropy.</p>
<p id="Par79">In order to calculate the <italic>pcgtAge</italic> and Shannon entropy acceleration, we followed a similar strategy to the one reported for EAA with CCC, fitting the following linear models:<list list-type="simple"><list-item><label>(V)</label><p id="Par80"><italic>pcgtAge</italic>~Ageâ+âSexâ+âGranâ+âCD4Tâ+âCD8Tâ+âBâ+âMonoâ+âNKâ+âPC1â+ââ¦â+âPC17</p></list-item><list-item><label>(VI)</label><p id="Par81">Entropy~Ageâ+âSexâ+âGranâ+âCD4Tâ+âCD8Tâ+âBâ+âMonoâ+âNKâ+âPC1â+ââ¦â+âPC17</p></list-item></list></p>
<p id="Par82">It is worth mentioning that we observed a remarkable effect of the batch on the Shannon entropy calculations, which generated high entropy variability for a given age (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S4C,D). Thus, accounting for technical variation becomes crucial when assessing this type of data, even after background correction, probe filtering, and BMIQ normalization.</p>
</sec>
<sec id="Sec16">
<title>Identifying differentially methylated positions</title>
<p id="Par83">DMPs were identified using a modified version of the <italic>dmpFinder</italic> function in the <italic>minfi</italic> R package [<xref ref-type="bibr" rid="CR82">82</xref>], where we accounted for other covariates. The aging DMPs (aDMPs) were calculated using the control samples that were included in the screen (age range 0â55âyears, <italic>N</italic>â=â1128) and the following linear model (<italic>p</italic> values and regression coefficients were extracted for the <italic>Age</italic> covariate):<list list-type="simple"><list-item><label>(VII)</label><p id="Par84"><italic>Î²</italic><sub><italic>i</italic></sub>~Ageâ+âSexâ+âGranâ+âCD4Tâ+âCD8Tâ+âBâ+âMonoâ+âNKâ+âPC1â+ââ¦â+âPC17</p></list-item></list>where <italic>Î²</italic><sub><italic>i</italic></sub> represents the methylation beta value for the <italic>i</italic>th probe (CpG site) in the array.</p>
<p id="Par85">The Sotos DMPs were calculated by comparing the Sotos samples (<italic>N</italic>â=â20) against the control samples (<italic>N</italic>â=â51) from the same dataset (GSE74432) [<xref ref-type="bibr" rid="CR44">44</xref>] using the following linear model (<italic>p</italic> values and regression coefficients were extracted for the <italic>Disease_status</italic> covariate):<list list-type="simple"><list-item><label>(VIII)</label><p id="Par86"><italic>Î²</italic><sub><italic>i</italic></sub>~Diseaseâ_âstatusâ+âAgeâ+âSexâ+âGranâ+âCD4Tâ+âCD8Tâ+âBâ+âMonoâ+âNKâ+âPC1â+ââ¦â+âPC17</p></list-item></list></p>
<p id="Par87">We selected as our final DMPs those CpG probes that survived our analysis after Bonferroni multiple testing correction with a significance level of <italic>Î±</italic>â=â0.01.</p>
</sec>
<sec id="Sec17">
<title>(Epi) genomic annotation of the CpG sites</title>
<p id="Par88">Different (epi) genomic features were extracted for the CpG sites of interest. All the data were mapped to the <italic>hg19</italic> assembly of the human genome.</p>
<p id="Par89">The continuous features were calculated by extracting the mean value in a window of Â±â200âbp from the CpG site coordinate using the <italic>pyBigWig</italic> package [<xref ref-type="bibr" rid="CR94">94</xref>]. We chose this window value based on the methylation correlation observed between neighboring CpG sites in previous studies [<xref ref-type="bibr" rid="CR95">95</xref>]. The continuous features included (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM5">5</xref>) the following:<list list-type="bullet"><list-item><p id="Par90">ChIP-seq data from ENCODE (histone modifications from peripheral blood mononuclear cells or PBMC; EZH2, as a marker of polycomb repressing complex 2 binding, from B cells; RNF2, as a marker of polycomb repressing complex 1 binding, from the K562 cell line). We obtained <italic>Z</italic>-scores (using the <italic>scale</italic> function in R) for the values of âfold change over controlâ as calculated in ENCODE [<xref ref-type="bibr" rid="CR96">96</xref>]. When needed, biological replicates of the same feature were aggregated by taking the mean of the <italic>Z</italic>-scores in order to obtain the ânormalised fold changeâ (NFC).</p></list-item><list-item><p id="Par91">ChIP-seq data for LaminB1 (GSM1289416, quantified as ânormalised read countsâ or NRC) and Repli-seq data for replication timing (GSM923447, quantified as âwavelet-transformed signalsâ or WTS). We used the same data from the IMR90 cell line as in [<xref ref-type="bibr" rid="CR97">97</xref>].</p></list-item><list-item><p id="Par92">Total RNA-seq data (rRNA depleted, from PBMC) from ENCODE. We calculated <italic>Z</italic>-scores after aggregating the âsignal of unique readsâ (<italic>sur</italic>) for both strands (+ and â) in the following manner:</p></list-item></list><list list-type="simple"><list-item><label>(IX)</label><p id="Par93">RNA<sub><italic>i</italic></sub>â=âlog<sub>2</sub>(1â+âsur<sub><italic>i</italic>+</sub>â+âsur<sub><italic>i</italic>â</sub>)</p></list-item></list>where RNA<sub><italic>i</italic></sub> represents the RNA signal (that then needs to be scaled to obtain the ânormalised RNA expressionâ or NRE) for the <italic>i</italic>th CpG site.</p>
<p id="Par94">The categorical features were obtained by looking at the overlap (using the <italic>pybedtools</italic> package) [<xref ref-type="bibr" rid="CR98">98</xref>] of the CpG sites with the following:<list list-type="bullet"><list-item><p id="Par95">Gene bodies, from protein-coding genes as defined in the basic gene annotation of GENCODE release 29 [<xref ref-type="bibr" rid="CR99">99</xref>].</p></list-item><list-item><p id="Par96">CpG islands (CGIs) were obtained from the UCSC Genome Browser [<xref ref-type="bibr" rid="CR100">100</xref>]. Shores were defined as regions 0 to 2âkb away from CGIs in both directions and shelves as regions 2 to 4âkb away from CGIs in both directions as previously described [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR101">101</xref>].</p></list-item><list-item><p id="Par97">Chromatin states were obtained from the K562 cell line in the Roadmap Epigenomics Project (based on imputed data, 25 states, 12 marks) [<xref ref-type="bibr" rid="CR102">102</xref>]. A visualization for the association between chromatin marks and chromatin states can be found in [<xref ref-type="bibr" rid="CR103">103</xref>]. When needed for visualization purposes, the 25 states were manually collapsed to a lower number of them.</p></list-item></list></p>
<p id="Par98">We compared the different genomic features for each one of our subsets of CpG sites (hypomethylated aDMPs, hypomethylated Sotos DMPs) against a control set. This control set was composed of all the probes from the background set from which we removed the subset that we were testing. In the case of the comparisons against the 353 Horvath clock CpG sites, a background set of the 21,368 (21K) CpG probes used to train the original Horvath model [<xref ref-type="bibr" rid="CR8">8</xref>] was used. In the case of the genome-wide comparisons for aging and Sotos syndrome, a background set containing all 428,266 probes that passed our pre-processing pipeline (450K) was used.</p>
<p id="Par99">The distributions of the scores from the continuous features were compared using a two-sided Wilcoxonâs test. In the case of the categorical features, we tested for enrichment using Fisherâs exact test.</p>
</sec>
<sec id="Sec18">
<title>Differences in the clock CpGs beta values for Sotos syndrome</title>
<p id="Par100">To compare the beta values of the Horvath clock CpG sites between our healthy samples and Sotos samples, we fitted the following linear models in the healthy samples (<italic>control CpG models</italic>, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3C, AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM6">6</xref>):<list list-type="simple"><list-item><label>(X)</label><p id="Par101"><italic>Î²</italic><sub><italic>i</italic></sub>~Ageâ+âAge<sup>2</sup>â+âSexâ+âGranâ+âCD4Tâ+âCD8Tâ+âBâ+âMonoâ+âNKâ+âPC1â+ââ¦â+âPC17</p></list-item></list>where <italic>Î²</italic><sub><italic>i</italic></sub> represents the methylation beta values for the <italic>i</italic>th probe (CpG site) in the 353 CpG clock sites. The Age<sup>2</sup> term allows accounting for non-linear relationships between chronological age and the beta values.</p>
<p id="Par102">Finally, we calculated the difference between the beta values in Sotos samples and the predictions from the <italic>control CpG models</italic> and displayed these differences in an annotated heatmap (AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM1">1</xref>: Figure S3D).</p>
</sec>
<sec id="Sec19">
<title>Code availability</title>
<p id="Par103">All the code used to perform the analyses here presented can be found in our GitHub repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/demh/epigenetic_ageing_clock">https://github.com/demh/epigenetic_ageing_clock</ext-link>) under GNU General Public License v3.0 [<xref ref-type="bibr" rid="CR84">84</xref>].</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Additional files</title>
<sec id="Sec20">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13059_2019_1753_MOESM1_ESM.pdf"><label>Additional file 1:</label><caption><p>Supplementary figures that complement the main manuscript. (PDF 2877 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13059_2019_1753_MOESM2_ESM.tsv"><label>Additional file 2:</label><caption><p>Information for the samples with developmental disorders (cases) that were included in the main screen (<italic>N</italic>â=â367). (TSV 216 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="13059_2019_1753_MOESM3_ESM.tsv"><label>Additional file 3:</label><caption><p>Information for the healthy control samples that were included in the main screen (<italic>N</italic>â=â1128). (TSV 633 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="13059_2019_1753_MOESM4_ESM.xlsx"><label>Additional file 4:</label><caption><p>Information about the different blood cell type deconvolution strategies that were benchmarked against the gold standard dataset (GSE77797). (XLSX 13 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="13059_2019_1753_MOESM5_ESM.csv"><label>Additional file 5:</label><caption><p>Information (including the source) about the continuous (epi) genomic features (ChIP-seq and RNA-seq data) that were included in our analysis to annotate the different sets of CpG sites. (CSV 1 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="13059_2019_1753_MOESM6_ESM.pdf"><label>Additional file 6:</label><caption><p>DNA methylation (beta value) profiles for the 353 Horvathâs epigenetic clock CpG sites during aging for healthy individuals (gray) and Sotos patients (orange). A linear model (displayed in dark gray) can be fixed to each CpG site to model the changes in beta value with chronological age in the controls (gray). Information about whether the site is a differentially methylated position during aging (aDMP) or in Sotos patients (Sotos DMP) is also provided. Hyper, hypermethylated; Hypo, hypomethylated; No, not statistically significant after Bonferroni correction. (PDF 2811 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="13059_2019_1753_MOESM7_ESM.docx"><label>Additional file 7:</label><caption><p>Review history. (DOCX 42 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>450K array</term>
<def>
<p id="Par4">Illumina Infinium HumanMethylation450 BeadChip</p>
</def>
</def-item>
<def-item>
<term>aDMPs</term>
<def>
<p id="Par5">Differentially methylated positions during aging</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p id="Par6">Autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term>ATR-X</term>
<def>
<p id="Par7">Alpha thalassemia/mental retardation X-linked syndrome</p>
</def>
</def-item>
<def-item>
<term>CCC</term>
<def>
<p id="Par8">Cell composition correction</p>
</def>
</def-item>
<def-item>
<term>DMPs</term>
<def>
<p id="Par9">Differentially methylated positions</p>
</def>
</def-item>
<def-item>
<term>EAA</term>
<def>
<p id="Par10">Epigenetic age acceleration</p>
</def>
</def-item>
<def-item>
<term>FXS</term>
<def>
<p id="Par11">Fragile X syndrome</p>
</def>
</def-item>
<def-item>
<term>IEAA</term>
<def>
<p id="Par12">Intrinsic epigenetic age acceleration</p>
</def>
</def-item>
<def-item>
<term>iPSCs</term>
<def>
<p id="Par13">Induced pluripotent stem cells</p>
</def>
</def-item>
<def-item>
<term>MAE</term>
<def>
<p id="Par14">Median absolute error</p>
</def>
</def-item>
<def-item>
<term>PBMC</term>
<def>
<p id="Par15">Peripheral blood mononuclear cells</p>
</def>
</def-item>
<def-item>
<term>PCA</term>
<def>
<p id="Par16">Principal component analysis</p>
</def>
</def-item>
<def-item>
<term>PCs</term>
<def>
<p id="Par17">Principal components</p>
</def>
</def-item>
<def-item>
<term>rRNA</term>
<def>
<p id="Par18">Ribosomal RNA</p>
</def>
</def-item>
<def-item>
<term>UTR</term>
<def>
<p id="Par19">Untranslated region</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisherâs Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>Wolf Reik and Janet M. Thornton jointly supervised this work.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>We thank all the members of the Reik and Thornton Laboratories for the helpful discussions. Specifically, we would like to acknowledge Melike DÃ¶nertas, Dr. Gos Micklem, and Dr. Judith Zaugg for their advice during the last years. Furthermore, we thank all the authors and groups that answered our emails, allowed us to use the raw DNA methylation data that they generated, and provided missing metadata, including Dr. Kimberly Aldinger, Dr. Sebastian MorÃ¡n, Dr. Manuel Castro, Dr. Juan Sandoval, Dr. Pankaj Chopra, Dr. Akdes Serin-Harmanci, Dr. Weng Khong Lim, Dr. Reiner Schulz, Tina Wang, Dr. Barry Demchack, and Professor Trey Ideker. Finally, we would like to thank Parvathi âAleâ Subbiah for designing the figure displaying our current working model.</p>
<sec id="FPar1">
<title>Review history</title>
<p id="Par104">The review history is available at AdditionalÂ fileÂ <xref ref-type="media" rid="MOESM7">7</xref>.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authorsâ contributions</title>
<p>DEMH, TMS, WR, and JMT designed the study. DEMH, EAE, and MJB conducted the data analysis. EAE, SC, RW, and BS generated part of the DNA methylation dataset. MJB and OS provided crucial statistical input. DEMH, WR, and JMT interpreted the data and wrote the manuscript. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>EMBL predoctoral fellowship (to DEMH); fellowship from the EMBL Interdisciplinary Postdoc (EI3POD) program under Marie SkÅodowska-Curie Actions COFUND (grant number 664726; to MJB). WR acknowledges funding from BBSRC. JMT acknowledges funding from EMBL.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>Part of the DNA methylation data and metadata was obtained from the GEO public repository and are available under the following accession numbers: GSE104812 [<xref ref-type="bibr" rid="CR104">104</xref>], GSE111629 [<xref ref-type="bibr" rid="CR105">105</xref>], GSE116300 [<xref ref-type="bibr" rid="CR106">106</xref>], GSE35069 (to build the reference for cell composition estimation) [<xref ref-type="bibr" rid="CR107">107</xref>], GSE40279 [<xref ref-type="bibr" rid="CR108">108</xref>], GSE41273 [<xref ref-type="bibr" rid="CR109">109</xref>], GSE42861 [<xref ref-type="bibr" rid="CR110">110</xref>], GSE51032 [<xref ref-type="bibr" rid="CR111">111</xref>], GSE55491 [<xref ref-type="bibr" rid="CR112">112</xref>], GSE59065 [<xref ref-type="bibr" rid="CR113">113</xref>], GSE61496 [<xref ref-type="bibr" rid="CR114">114</xref>], GSE74432 [<xref ref-type="bibr" rid="CR115">115</xref>], GSE77797 (gold-standard for cell composition estimation) [<xref ref-type="bibr" rid="CR116">116</xref>], GSE81961 [<xref ref-type="bibr" rid="CR117">117</xref>], and GSE97362 [<xref ref-type="bibr" rid="CR118">118</xref>]. The rest of the raw DNA methylation data (Europe, Feb_2016, Jun_2015, Mar_2014, May_2015, May_2016, Nov_2015, Oct_2014) are not publicly available at the time of the study as part of the conditions of the research ethical approval of the study. All the code used to perform the analyses here presented can be found in the following GitHub repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/demh/epigenetic_ageing_clock">https://github.com/demh/epigenetic_ageing_clock</ext-link>) under the GNU General Public License v3.0 [<xref ref-type="bibr" rid="CR84">84</xref>].</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par105">The study protocol has been approved by the Western University Research Ethics Board (REB ID 106302) and McMaster University and the Hamilton Integrated Research Ethics Boards (REB ID 13-653-T). All of the participants provided informed consent prior to sample collection. All of the samples and records were de-identified before any experimental or analytical procedures. The research was conducted in accordance with all relevant ethical regulations. All experimental methods comply with the Helsinki Declaration.</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par106">Not applicable.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par107">DEMH and TMS are founders and shareholders of Chronomics Limited, a UK-based company that provides epigenetic testing. WR is a consultant and shareholder of Cambridge Epigenetix. All other authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Otin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Blasco</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Partridge</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Serrano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kroemer</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The hallmarks of aging</article-title>
<source/>Cell.
          <year>2013</year>
<volume>153</volume>
<fpage>1194</fpage>
<lpage>1217</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.05.039</pub-id>
<pub-id pub-id-type="pmid">23746838</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benayoun</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Pollina</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Brunet</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Epigenetic regulation of ageing: linking environmental inputs to genomic stability</article-title>
<source/>Nat Rev Mol Cell Biol
          <year>2015</year>
<volume>16</volume>
<fpage>593</fpage>
<lpage>610</lpage>
<pub-id pub-id-type="doi">10.1038/nrm4048</pub-id>
<pub-id pub-id-type="pmid">26373265</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Nativio</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Epigenetic mechanisms of longevity and aging</article-title>
<source/>Cell.
          <year>2016</year>
<volume>166</volume>
<fpage>822</fpage>
<lpage>839</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2016.07.050</pub-id>
<pub-id pub-id-type="pmid">27518561</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tyler</surname>
<given-names>JK</given-names>
</name>
</person-group>
<article-title>Epigenetics and aging</article-title>
<source/>Sci Adv
          <year>2016</year>
<volume>2</volume>
<fpage>e1600584</fpage>
<pub-id pub-id-type="doi">10.1126/sciadv.1600584</pub-id>
<pub-id pub-id-type="pmid">27482540</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>DNA methylation-based biomarkers and the epigenetic clock theory of ageing</article-title>
<source/>Nat Rev Genet
          <year>2018</year>
<volume>19</volume>
<fpage>371</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1038/s41576-018-0004-3</pub-id>
<pub-id pub-id-type="pmid">29643443</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Field</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Havas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ideker</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>DNA methylation clocks in aging: categories, causes, and consequences</article-title>
<source/>Mol Cell
          <year>2018</year>
<volume>71</volume>
<fpage>882</fpage>
<lpage>895</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2018.08.008</pub-id>
<pub-id pub-id-type="pmid">30241605</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Epigenetic-aging-signature to determine age in different tissues</article-title>
<source/>Aging (Albany NY)
          <year>2011</year>
<volume>3</volume>
<fpage>1018</fpage>
<lpage>1027</lpage>
<pub-id pub-id-type="doi">10.18632/aging.100395</pub-id>
<pub-id pub-id-type="pmid">22067257</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>DNA methylation age of human tissues and cell types</article-title>
<source/>Genome Biol
          <year>2013</year>
<volume>14</volume>
<fpage>3156</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2013-14-10-r115</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannum</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Guinney</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sadda</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Genome-wide methylation profiles reveal quantitative views of human aging rates</article-title>
<source/>Mol Cell
          <year>2013</year>
<volume>49</volume>
<fpage>359</fpage>
<lpage>367</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2012.10.016</pub-id>
<pub-id pub-id-type="pmid">23177740</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stubbs</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Bonder</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>A-K</given-names>
</name>
<name>
<surname>Krueger</surname>
<given-names>F</given-names>
</name>
<name>
<surname>von Meyenn</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Stegle</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multi-tissue DNA methylation age predictor in mouse</article-title>
<source/>Genome Biol
          <year>2017</year>
<volume>18</volume>
<fpage>68</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-017-1203-5</pub-id>
<pub-id pub-id-type="pmid">28399939</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petkovich</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Podolskiy</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Lobanov</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S-G</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Gladyshev</surname>
<given-names>VN</given-names>
</name>
</person-group>
<article-title>Using DNA methylation profiling to evaluate biological age and longevity interventions</article-title>
<source/>Cell Metab
          <year>2017</year>
<volume>25</volume>
<fpage>954</fpage>
<lpage>960.e6</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2017.03.016</pub-id>
<pub-id pub-id-type="pmid">28380383</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tsui</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kreisberg</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>MK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment</article-title>
<source/>Genome Biol
          <year>2017</year>
<volume>18</volume>
<fpage>57</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-017-1186-2</pub-id>
<pub-id pub-id-type="pmid">28351423</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>ChwiaÅkowska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rubbi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lusis</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A multi-tissue full lifespan epigenetic clock for mice</article-title>
<source/>Aging (Albany NY)
          <year>2018</year>
<volume>10</volume>
<fpage>2832</fpage>
<lpage>2854</lpage>
<pub-id pub-id-type="doi">10.18632/aging.101590</pub-id>
<pub-id pub-id-type="pmid">30348905</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meer</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Podolskiy</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Tyshkovskiy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gladyshev</surname>
<given-names>VN</given-names>
</name>
</person-group>
<article-title>A whole lifespan mouse multi-tissue DNA methylation clock</article-title>
<source/>Elife.
          <year>2018</year>
<volume>7</volume>
<fpage>e40675</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.40675</pub-id>
<pub-id pub-id-type="pmid">30427307</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>von Holdt</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pellegrini</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>An epigenetic aging clock for dogs and wolves</article-title>
<source/>Aging (Albany NY)
          <year>2017</year>
<volume>9</volume>
<fpage>1055</fpage>
<lpage>1068</lpage>
<pub-id pub-id-type="doi">10.18632/aging.101211</pub-id>
<pub-id pub-id-type="pmid">28373601</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polanowski</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jarman</surname>
<given-names>SN</given-names>
</name>
</person-group>
<article-title>Epigenetic estimation of age in humpback whales</article-title>
<source/>Mol Ecol Resour
          <year>2014</year>
<volume>14</volume>
<fpage>976</fpage>
<lpage>987</lpage>
<pub-id pub-id-type="pmid">24606053</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marioni</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S</given-names>
</name>
<name>
<surname>McRae</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Colicino</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>SE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DNA methylation age of blood predicts all-cause mortality in later life</article-title>
<source/>Genome Biol
          <year>2015</year>
<volume>16</volume>
<fpage>25</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-015-0584-6</pub-id>
<pub-id pub-id-type="pmid">25633388</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Marioni</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Colicino</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Ward-Caviness</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>PC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DNA methylation-based measures of biological age: meta-analysis predicting time to death</article-title>
<source/>Aging (Albany NY)
          <year>2016</year>
<volume>8</volume>
<fpage>1844</fpage>
<lpage>1865</lpage>
<pub-id pub-id-type="doi">10.18632/aging.101020</pub-id>
<pub-id pub-id-type="pmid">27690265</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>HIV-1 infection accelerates age according to the epigenetic clock</article-title>
<source/>J Infect Dis
          <year>2015</year>
<volume>212</volume>
<fpage>1563</fpage>
<lpage>1573</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jiv277</pub-id>
<pub-id pub-id-type="pmid">25969563</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Garagnani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bacalini</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Pirazzini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Salvioli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gentilini</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Accelerated epigenetic aging in Down syndrome</article-title>
<source/>Aging Cell
          <year>2015</year>
<volume>14</volume>
<fpage>491</fpage>
<lpage>495</lpage>
<pub-id pub-id-type="doi">10.1111/acel.12325</pub-id>
<pub-id pub-id-type="pmid">25678027</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Erhart</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Brosch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ammerpohl</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>von Schonfels</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ahrens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Heits</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>P.-C.</given-names>
</name>
<name>
<surname>Spector</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Deloukas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Siebert</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sipos</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rocken</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schafmayer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hampe</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Obesity accelerates epigenetic aging of human liver</article-title>
<source/>Proceedings of the National Academy of Sciences
          <year>2014</year>
<volume>111</volume>
<issue>43</issue>
<fpage>15538</fpage>
<lpage>15543</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1412759111</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maierhofer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Flunkert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oshima</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Haaf</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Accelerated epigenetic aging in Werner syndrome</article-title>
<source/>Aging (Albany NY)
          <year>2017</year>
<volume>9</volume>
<fpage>1143</fpage>
<lpage>1152</lpage>
<pub-id pub-id-type="doi">10.18632/aging.101217</pub-id>
<pub-id pub-id-type="pmid">28377537</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Langfelder</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kwak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aaronson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rosinski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vogt</surname>
<given-names>TF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Huntingtonâs disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels</article-title>
<source/>Aging (Albany NY)
          <year>2016</year>
<volume>8</volume>
<fpage>1485</fpage>
<lpage>1512</lpage>
<pub-id pub-id-type="doi">10.18632/aging.101005</pub-id>
<pub-id pub-id-type="pmid">27479945</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Ritz</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ophoff</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epigenetic age analysis of children who seem to evade aging</article-title>
<source/>Aging (Albany NY)
          <year>2015</year>
<volume>7</volume>
<fpage>334</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="doi">10.18632/aging.100744</pub-id>
<pub-id pub-id-type="pmid">25991677</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cole</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Rather</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>McBryan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sproul</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions</article-title>
<source/>Genome Biol
          <year>2017</year>
<volume>18</volume>
<fpage>58</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-017-1185-3</pub-id>
<pub-id pub-id-type="pmid">28351383</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rando</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock</article-title>
<source/>Cell.
          <year>2012</year>
<volume>148</volume>
<fpage>46</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.01.003</pub-id>
<pub-id pub-id-type="pmid">22265401</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olova</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Marioni</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity</article-title>
<source/>Aging Cell
          <year>2019</year>
<volume>18</volume>
<fpage>e12877</fpage>
<pub-id pub-id-type="doi">10.1111/acel.12877</pub-id>
<pub-id pub-id-type="pmid">30450724</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Salfati</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Ferrucci</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GWAS of epigenetic aging rates in blood reveals a critical role for TERT</article-title>
<source/>Nat Commun
          <year>2018</year>
<volume>9</volume>
<fpage>387</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-017-02697-5</pub-id>
<pub-id pub-id-type="pmid">29374233</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Hannon</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Crimmins</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Lunnon</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic variants near MLST8 and DHX57 affect the epigenetic age of the cerebellum</article-title>
<source/>Nat Commun
          <year>2016</year>
<volume>7</volume>
<fpage>10561</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms10561</pub-id>
<pub-id pub-id-type="pmid">26830004</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bjornsson</surname>
<given-names>HT</given-names>
</name>
</person-group>
<article-title>The Mendelian disorders of the epigenetic machinery</article-title>
<source/>Genome Res
          <year>2015</year>
<volume>25</volume>
<fpage>1473</fpage>
<lpage>1481</lpage>
<pub-id pub-id-type="doi">10.1101/gr.190629.115</pub-id>
<pub-id pub-id-type="pmid">26430157</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aref-Eshghi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rodenhiser</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Schenkel</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ainsworth</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomic DNA methylation signatures enable concurrent diagnosis and clinical genetic variant classification in neurodevelopmental syndromes</article-title>
<source/>Am J Hum Genet
          <year>2018</year>
<volume>102</volume>
<fpage>156</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2017.12.008</pub-id>
<pub-id pub-id-type="pmid">29304373</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoshino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sridhar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chitsazan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Reh</surname>
<given-names>TA</given-names>
</name>
</person-group>
<article-title>Synchrony and asynchrony between an epigenetic clock and developmental timing</article-title>
<source/>Sci Rep
          <year>2019</year>
<volume>9</volume>
<fpage>3770</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-019-39919-3</pub-id>
<pub-id pub-id-type="pmid">30842553</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gagnon-Bartsch</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Speed</surname>
<given-names>TP</given-names>
</name>
</person-group>
<article-title>Using control genes to correct for unwanted variation in microarray data</article-title>
<source/>Biostatistics.
          <year>2012</year>
<volume>13</volume>
<fpage>539</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1093/biostatistics/kxr034</pub-id>
<pub-id pub-id-type="pmid">22101192</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fortin</surname>
<given-names>J-P</given-names>
</name>
<name>
<surname>Labbe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lemire</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zanke</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Fertig</surname>
<given-names>EJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional normalization of 450k methylation array data improves replication in large cancer studies</article-title>
<source/>Genome Biol
          <year>2014</year>
<volume>15</volume>
<fpage>503</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-014-0503-2</pub-id>
<pub-id pub-id-type="pmid">25599564</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maksimovic</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oshlack</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gagnon-Bartsch</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Speed</surname>
<given-names>TP</given-names>
</name>
</person-group>
<article-title>Removing unwanted variation in a differential methylation analysis of Illumina HumanMethylation450 array data</article-title>
<source/>Nucleic Acids Res
          <year>2015</year>
<volume>43</volume>
<fpage>e106</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv526</pub-id>
<pub-id pub-id-type="pmid">25990733</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<mixed-citation publication-type="other">El Khoury LY, Gorrie-Stone T, Smart M, Hughes A, Bao Y, Andrayas A, et al. Properties of the epigenetic clock and age acceleration. bioRxiv. 2018:363143.</mixed-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marioni</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Deary</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Relton</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Suderman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ferrucci</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>BH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tracking the epigenetic clock across the human life course: a meta-analysis of longitudinal cohort data</article-title>
<source/>J Gerontol Ser A
          <year>2018</year>
<volume>74</volume>
<fpage>57</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1093/gerona/gly060</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gurven</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Trumble</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Allayee</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease</article-title>
<source/>Genome Biol
          <year>2016</year>
<volume>17</volume>
<fpage>171</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-016-1030-0</pub-id>
<pub-id pub-id-type="pmid">27511193</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kuh</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Rakyan</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Leslie</surname>
<given-names>RD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Correlation of an epigenetic mitotic clock with cancer risk</article-title>
<source/>Genome Biol
          <year>2016</year>
<volume>17</volume>
<fpage>205</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-016-1064-3</pub-id>
<pub-id pub-id-type="pmid">27716309</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Weidner</surname>
<given-names>CI</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>IG</given-names>
</name>
<name>
<surname>Marioni</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>MRP</given-names>
</name>
<name>
<surname>Deary</surname>
<given-names>IJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DNA methylation levels at individual age-associated CpG sites can be indicative for life expectancy</article-title>
<source/>Aging (Albany NY)
          <year>2016</year>
<volume>8</volume>
<fpage>394</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="doi">10.18632/aging.100908</pub-id>
<pub-id pub-id-type="pmid">26928272</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oshima</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Quach</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epigenetic clock for skin and blood cells applied to Hutchinson Gilford progeria syndrome and ex vivo studies</article-title>
<source/>Aging (Albany NY)
          <year>2018</year>
<volume>10</volume>
<fpage>1758</fpage>
<lpage>1775</lpage>
<pub-id pub-id-type="doi">10.18632/aging.101508</pub-id>
<pub-id pub-id-type="pmid">30048243</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leventopoulos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kitsiou-Tzeli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kritikos</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Psoni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mavrou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kanavakis</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A clinical study of Sotos syndrome patients with review of the literature</article-title>
<source/>Pediatr Neurol
          <year>2009</year>
<volume>40</volume>
<fpage>357</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2008.11.013</pub-id>
<pub-id pub-id-type="pmid">19380072</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurotaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Imaizumi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Masuno</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kondoh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Haploinsufficiency of NSD1 causes Sotos syndrome</article-title>
<source/>Nat Genet
          <year>2002</year>
<volume>30</volume>
<fpage>365</fpage>
<lpage>366</lpage>
<pub-id pub-id-type="doi">10.1038/ng863</pub-id>
<pub-id pub-id-type="pmid">11896389</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choufani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cytrynbaum</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>BHY</given-names>
</name>
<name>
<surname>Turinsky</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Grafodatskaya</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>YA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NSD1 mutations generate a genome-wide DNA methylation signature</article-title>
<source/>Nat Commun
          <year>2015</year>
<volume>6</volume>
<fpage>10207</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms10207</pub-id>
<pub-id pub-id-type="pmid">26690673</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Teschendorff</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Cell and tissue type independent age-associated DNA methylation changes are not rare but common</article-title>
<source/>Aging (Albany NY)
          <year>2018</year>
<volume>10</volume>
<fpage>3541</fpage>
<lpage>3557</lpage>
<pub-id pub-id-type="doi">10.18632/aging.101666</pub-id>
<pub-id pub-id-type="pmid">30482885</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slieker</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>van Iterson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Luijk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Beekman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhernakova</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Moed</surname>
<given-names>MH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Age-related accrual of methylomic variability is linked to fundamental ageing mechanisms</article-title>
<source/>Genome Biol
          <year>2016</year>
<volume>17</volume>
<fpage>191</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-016-1053-6</pub-id>
<pub-id pub-id-type="pmid">27654999</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slieker</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Relton</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Gaunt</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Slagboom</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Heijmans</surname>
<given-names>BT</given-names>
</name>
</person-group>
<article-title>Age-related DNA methylation changes are tissue-specific with ELOVL2 promoter methylation as exception</article-title>
<source/>Epigenetics Chromatin
          <year>2018</year>
<volume>11</volume>
<fpage>25</fpage>
<pub-id pub-id-type="doi">10.1186/s13072-018-0191-3</pub-id>
<pub-id pub-id-type="pmid">29848354</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rinaldi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Datta</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Serrat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Morey</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Solanas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Avgustinova</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis</article-title>
<source/>Cell Stem Cell
          <year>2016</year>
<volume>19</volume>
<fpage>491</fpage>
<lpage>501</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2016.06.020</pub-id>
<pub-id pub-id-type="pmid">27476967</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernstein</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Mikkelsen</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kamal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huebert</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Cuff</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A bivalent chromatin structure marks key developmental genes in embryonic stem cells</article-title>
<source/>Cell.
          <year>2006</year>
<volume>125</volume>
<fpage>315</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2006.02.041</pub-id>
<pub-id pub-id-type="pmid">16630819</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernhart</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Kretzmer</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Holdt</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>JÃ¼hling</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ammerpohl</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>AK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Changes of bivalent chromatin coincide with increased expression of developmental genes in cancer</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>37393</fpage>
<pub-id pub-id-type="doi">10.1038/srep37393</pub-id>
<pub-id pub-id-type="pmid">27876760</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<mixed-citation publication-type="other">Horvath S. DNAmAge online calculator: <ext-link ext-link-type="uri" xlink:href="https://dnamage.genetics.ucla.edu/home">https://dnamage.genetics.ucla.edu/home</ext-link>. 2013. <ext-link ext-link-type="uri" xlink:href="https://dnamage.genetics.ucla.edu/home">https://dnamage.genetics.ucla.edu/home</ext-link>.</mixed-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Carpenter</surname>
<given-names>PB</given-names>
</name>
</person-group>
<article-title>Understanding the language of Lys36 methylation at histone H3</article-title>
<source/>Nat Rev Mol Cell Biol.
          <year>2012</year>
<volume>13</volume>
<fpage>115</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="doi">10.1038/nrm3274</pub-id>
<pub-id pub-id-type="pmid">22266761</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luscan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Laurendeau</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Malan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Francannet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Odent</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Giuliano</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in SETD2 cause a novel overgrowth condition</article-title>
<source/>J Med Genet
          <year>2014</year>
<volume>51</volume>
<fpage>512</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2014-102402</pub-id>
<pub-id pub-id-type="pmid">24852293</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDaniel</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Hepperla</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dronamraju</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Kulkarni</surname>
<given-names>VG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>H3K36 methylation regulates nutrient stress response in Saccharomyces cerevisiae by enforcing transcriptional fidelity</article-title>
<source/>Cell Rep
          <year>2017</year>
<volume>19</volume>
<fpage>2371</fpage>
<lpage>2382</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.05.057</pub-id>
<pub-id pub-id-type="pmid">28614721</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ni</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ebata</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alipanahiramandi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SS</given-names>
</name>
</person-group>
<article-title>Two SET domain containing genes link epigenetic changes and aging in Caenorhabditis elegans</article-title>
<source/>Aging Cell
          <year>2012</year>
<volume>11</volume>
<fpage>315</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="doi">10.1111/j.1474-9726.2011.00785.x</pub-id>
<pub-id pub-id-type="pmid">22212395</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Donahue</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dorsey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>H3K36 methylation promotes longevity by enhancing transcriptional fidelity</article-title>
<source/>Genes Dev
          <year>2015</year>
<volume>29</volume>
<fpage>1362</fpage>
<lpage>1376</lpage>
<pub-id pub-id-type="doi">10.1101/gad.263707.115</pub-id>
<pub-id pub-id-type="pmid">26159996</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Helfand</surname>
<given-names>SL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Trimethylation of Lys36 on H3 restricts gene expression change during aging and impacts life span</article-title>
<source/>Genes Dev
          <year>2015</year>
<volume>29</volume>
<fpage>718</fpage>
<lpage>731</lpage>
<pub-id pub-id-type="doi">10.1101/gad.254144.114</pub-id>
<pub-id pub-id-type="pmid">25838541</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>SchÃ¼beler</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Function and information content of DNA methylation</article-title>
<source/>Nature.
          <year>2015</year>
<volume>517</volume>
<fpage>321</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="doi">10.1038/nature14192</pub-id>
<pub-id pub-id-type="pmid">25592537</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhayalan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rajavelu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rathert</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tamas</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jurkowska</surname>
<given-names>RZ</given-names>
</name>
<name>
<surname>Ragozin</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation</article-title>
<source/>J Biol Chem
          <year>2010</year>
<volume>285</volume>
<fpage>26114</fpage>
<lpage>26120</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M109.089433</pub-id>
<pub-id pub-id-type="pmid">20547484</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baubec</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Colombo</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Wirbelauer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Krebs</surname>
<given-names>AR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation</article-title>
<source/>Nature.
          <year>2015</year>
<volume>520</volume>
<fpage>243</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.1038/nature14176</pub-id>
<pub-id pub-id-type="pmid">25607372</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heyn</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Logan</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Fluteau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Challis</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Auchynnikava</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>C-A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gain-of-function DNMT3A mutations cause microcephalic dwarfism and hypermethylation of Polycomb-regulated regions</article-title>
<source/>Nat Genet
          <year>2019</year>
<volume>51</volume>
<fpage>96</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1038/s41588-018-0274-x</pub-id>
<pub-id pub-id-type="pmid">30478443</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rakyan</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Down</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Maslau</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Andrew</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Beyan</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains</article-title>
<source/>Genome Res
          <year>2010</year>
<volume>20</volume>
<fpage>434</fpage>
<lpage>439</lpage>
<pub-id pub-id-type="doi">10.1101/gr.103101.109</pub-id>
<pub-id pub-id-type="pmid">20219945</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teschendorff</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Gentry-Maharaj</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ramus</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Weisenberger</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer</article-title>
<source/>Genome Res
          <year>2010</year>
<volume>20</volume>
<fpage>440</fpage>
<lpage>446</lpage>
<pub-id pub-id-type="doi">10.1101/gr.103606.109</pub-id>
<pub-id pub-id-type="pmid">20219944</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Lister</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Rajagopal</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epigenomic analysis of multilineage differentiation of human embryonic stem cells</article-title>
<source/>Cell.
          <year>2013</year>
<volume>153</volume>
<fpage>1134</fpage>
<lpage>1148</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.04.022</pub-id>
<pub-id pub-id-type="pmid">23664764</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Heger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Blackledge</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Kutter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epigenetic conservation at gene regulatory elements revealed by non-methylated DNA profiling in seven vertebrates</article-title>
<source/>Elife.
          <year>2013</year>
<volume>2</volume>
<fpage>e00348</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.00348</pub-id>
<pub-id pub-id-type="pmid">23467541</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Challen</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Large conserved domains of low DNA methylation maintained by Dnmt3a</article-title>
<source/>Nat Genet
          <year>2013</year>
<volume>46</volume>
<fpage>17</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2836</pub-id>
<pub-id pub-id-type="pmid">24270360</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide analyses reveal a role of Polycomb in promoting hypomethylation of DNA methylation valleys</article-title>
<source/>Genome Biol
          <year>2018</year>
<volume>19</volume>
<fpage>18</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-018-1390-8</pub-id>
<pub-id pub-id-type="pmid">29422066</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chantalat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Depaux</surname>
<given-names>A</given-names>
</name>
<name>
<surname>HÃ©ry</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Barral</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thuret</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Dimitrov</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Histone H3 trimethylation at lysine 36 is associated with constitutive and facultative heterochromatin</article-title>
<source/>Genome Res
          <year>2011</year>
<volume>21</volume>
<fpage>1426</fpage>
<lpage>1437</lpage>
<pub-id pub-id-type="doi">10.1101/gr.118091.110</pub-id>
<pub-id pub-id-type="pmid">21803857</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tsujimoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin</article-title>
<source/>Mol Cell Biol
          <year>2004</year>
<volume>24</volume>
<fpage>9048</fpage>
<lpage>9058</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.24.20.9048-9058.2004</pub-id>
<pub-id pub-id-type="pmid">15456878</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rothbart</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W-Y</given-names>
</name>
<name>
<surname>Tripathy</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An H3K36 methylation-engaging Tudor motif of Polycomb-like proteins mediates PRC2 complex targeting</article-title>
<source/>Mol Cell
          <year>2013</year>
<volume>49</volume>
<fpage>571</fpage>
<lpage>582</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2012.11.026</pub-id>
<pub-id pub-id-type="pmid">23273982</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liefke</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kurland</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Polycomb-like proteins link the PRC2 complex to CpG islands</article-title>
<source/>Nature.
          <year>2017</year>
<volume>549</volume>
<fpage>287</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1038/nature23881</pub-id>
<pub-id pub-id-type="pmid">28869966</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<mixed-citation publication-type="other">Jeffries AR, Maroofian R, Salter CG, Chioza BA, Cross HE, Patton MA, et al. Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging. bioRxiv. 2018:477356.</mixed-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rapelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Krepelova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Incarnato</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Parlato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intragenic DNA methylation prevents spurious transcription initiation</article-title>
<source/>Nature.
          <year>2017</year>
<volume>543</volume>
<fpage>72</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1038/nature21373</pub-id>
<pub-id pub-id-type="pmid">28225755</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally</article-title>
<source/>Nature.
          <year>2019</year>
<volume>567</volume>
<fpage>414</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-019-1016-7</pub-id>
<pub-id pub-id-type="pmid">30867593</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Min</surname>
<given-names>K-W</given-names>
</name>
<name>
<surname>Zealy</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Davila</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fomin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Makowsky</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Profiling of m6A RNA modifications identified an age-associated regulation of AGO2 mRNA stability</article-title>
<source/>Aging Cell
          <year>2018</year>
<volume>17</volume>
<fpage>e12753</fpage>
<pub-id pub-id-type="doi">10.1111/acel.12753</pub-id>
<pub-id pub-id-type="pmid">29573145</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Streubel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jammula</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Scelfo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fitzpatrick</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Oliviero</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The H3K36me2 methyltransferase Nsd1 demarcates PRC2-mediated H3K27me2 and H3K27me3 domains in embryonic stem cells</article-title>
<source/>Mol Cell
          <year>2018</year>
<volume>70</volume>
<fpage>371</fpage>
<lpage>379.e5</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2018.02.027</pub-id>
<pub-id pub-id-type="pmid">29606589</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butcher</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Cytrynbaum</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Turinsky</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Siu</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Inbar-Feigenberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mendoza-Londono</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CHARGE and Kabuki syndromes: gene-specific DNA methylation signatures identify epigenetic mechanisms linking these clinically overlapping conditions</article-title>
<source/>Am J Hum Genet
          <year>2017</year>
<volume>100</volume>
<fpage>773</fpage>
<lpage>788</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2017.04.004</pub-id>
<pub-id pub-id-type="pmid">28475860</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aref-Eshghi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Schenkel</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ainsworth</surname>
<given-names>P</given-names>
</name>
<name>
<surname>ParÃ©</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance</article-title>
<source/>Epigenetics.
          <year>2017</year>
<volume>12</volume>
<fpage>923</fpage>
<lpage>933</lpage>
<pub-id pub-id-type="doi">10.1080/15592294.2017.1381807</pub-id>
<pub-id pub-id-type="pmid">28933623</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Froimchuk</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Histone H3 lysine 4 methyltransferase KMT2D</article-title>
<source/>Gene.
          <year>2017</year>
<volume>627</volume>
<fpage>337</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2017.06.056</pub-id>
<pub-id pub-id-type="pmid">28669924</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schenkel</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rodenhiser</surname>
<given-names>DI</given-names>
</name>
<name>
<surname>Ainsworth</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Pare</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical validation of fragile X syndrome screening by DNA methylation array</article-title>
<source/>J Mol Diagnostics
          <year>2016</year>
<volume>18</volume>
<fpage>834</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="doi">10.1016/j.jmoldx.2016.06.005</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLaren</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Riat</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>GRS</given-names>
</name>
<name>
<surname>Thormann</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Ensembl variant effect predictor</article-title>
<source/>Genome Biol
          <year>2016</year>
<volume>17</volume>
<fpage>122</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-016-0974-4</pub-id>
<pub-id pub-id-type="pmid">27268795</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aryee</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jaffe</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Corrada-Bravo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ladd-Acosta</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Feinberg</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>KD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays</article-title>
<source/>Bioinformatics.
          <year>2014</year>
<volume>30</volume>
<fpage>1363</fpage>
<lpage>1369</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btu049</pub-id>
<pub-id pub-id-type="pmid">24478339</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Triche</surname>
<given-names>TJ</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Weisenberger</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Van Den Berg</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Laird</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Siegmund</surname>
<given-names>KD</given-names>
</name>
</person-group>
<article-title>Low-level processing of Illumina Infinium DNA Methylation BeadArrays</article-title>
<source/>Nucleic Acids Res
          <year>2013</year>
<volume>41</volume>
<fpage>e90</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gkt090</pub-id>
<pub-id pub-id-type="pmid">23476028</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<mixed-citation publication-type="other">Martin-Herranz DE. demh/epigenetic_ageing_clock: Epigenetic ageing clock v1.1.0. GitHub repository: <ext-link ext-link-type="uri" xlink:href="https://github.com/demh/epigenetic_ageing_clock/">https://github.com/demh/epigenetic_ageing_clock/</ext-link>. 2019. doi:10.5281/zenodo.3263907.</mixed-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Illumina</collab>
</person-group>
<source/>GenomeStudioÂ® methylation module v1.8 User Guide
          <year>2010</year>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Akalin</surname>
<given-names>A</given-names>
</name>
</person-group>
<source/>AmpliconBiSeq GitHub repository: findElbow function
          <year>2014</year>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teschendorff</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Cell-type deconvolution in epigenome-wide association studies: a review and recommendations</article-title>
<source/>Epigenomics.
          <year>2017</year>
<volume>9</volume>
<fpage>757</fpage>
<lpage>768</lpage>
<pub-id pub-id-type="doi">10.2217/epi-2016-0153</pub-id>
<pub-id pub-id-type="pmid">28517979</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houseman</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Accomando</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Koestler</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Marsit</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>HH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DNA methylation arrays as surrogate measures of cell mixture distribution</article-title>
<source/>BMC Bioinformatics.
          <year>2012</year>
<volume>13</volume>
<fpage>86</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-13-86</pub-id>
<pub-id pub-id-type="pmid">22568884</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koestler</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Usset</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Kobor</surname>
<given-names>MS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Improving cell mixture deconvolution by identifying optimal DNA methylation libraries (IDOL)</article-title>
<source/>BMC Bioinformatics
          <year>2016</year>
<volume>17</volume>
<fpage>120</fpage>
<pub-id pub-id-type="doi">10.1186/s12859-016-0943-7</pub-id>
<pub-id pub-id-type="pmid">26956433</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reinius</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Acevedo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Joerink</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pershagen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>DahlÃ©n</surname>
<given-names>S-E</given-names>
</name>
<name>
<surname>Greco</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<fpage>e41361</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0041361</pub-id>
<pub-id pub-id-type="pmid">22848472</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Teschendorff</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>SC</given-names>
</name>
</person-group>
<source/>EpiDISH bioconductor package
          <year>2017</year>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lemire</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Choufani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Butcher</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Grafodatskaya</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zanke</surname>
<given-names>BW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray</article-title>
<source/>Epigenetics.
          <year>2013</year>
<volume>8</volume>
<fpage>203</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.4161/epi.23470</pub-id>
<pub-id pub-id-type="pmid">23314698</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teschendorff</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Marabita</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lechner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bartlett</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tegner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gomez-Cabrero</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A beta-mixture quantile normalisation method for correcting probe design bias in Illumina Infinium 450k DNA methylation data</article-title>
<source/>Bioinformatics.
          <year>2012</year>
<volume>29</volume>
<fpage>189</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bts680</pub-id>
<pub-id pub-id-type="pmid">23175756</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<mixed-citation publication-type="other">Richter AS, Ryan DP, Kilpert F, RamÃ­rez F, Heyne S, Manke T. pyBigWig GitHub Repository. <ext-link ext-link-type="uri" xlink:href="https://github.com/deeptools/pyBigWig">https://github.com/deeptools/pyBigWig</ext-link>.</mixed-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Spector</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Deloukas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Engelhardt</surname>
<given-names>BE</given-names>
</name>
</person-group>
<article-title>Predicting genome-wide DNA methylation using methylation marks, genomic position, and DNA regulatory elements</article-title>
<source/>Genome Biol
          <year>2015</year>
<volume>16</volume>
<fpage>14</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-015-0581-9</pub-id>
<pub-id pub-id-type="pmid">25616342</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Consortium</surname>
<given-names>TEP</given-names>
</name>
<name>
<surname>Dunham</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kundaje</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aldred</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>
<source/>Nature.
          <year>2012</year>
<volume>489</volume>
<fpage>57</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1038/nature11247</pub-id>
<pub-id pub-id-type="pmid">22955616</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Dinh</surname>
<given-names>HQ</given-names>
</name>
<name>
<surname>Ramjan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Weisenberger</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Nicolet</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DNA methylation loss in late-replicating domains is linked to mitotic cell division</article-title>
<source/>Nat Genet
          <year>2018</year>
<volume>50</volume>
<fpage>591</fpage>
<lpage>602</lpage>
<pub-id pub-id-type="doi">10.1038/s41588-018-0073-4</pub-id>
<pub-id pub-id-type="pmid">29610480</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dale</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Quinlan</surname>
<given-names>AR</given-names>
</name>
</person-group>
<article-title>Pybedtools: a flexible Python library for manipulating genomic datasets and annotations</article-title>
<source/>Bioinformatics.
          <year>2011</year>
<volume>27</volume>
<fpage>3423</fpage>
<lpage>3424</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btr539</pub-id>
<pub-id pub-id-type="pmid">21949271</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frankish</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bignell</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>BM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GENCODE reference annotation for the human and mouse genomes</article-title>
<source/>Nucleic Acids Res
          <year>2018</year>
<volume>47</volume>
<fpage>D766</fpage>
<lpage>D773</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gky955</pub-id>
<pub-id pub-id-type="pmid">6323946</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bock</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Paulsen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lengauer</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>CpG island mapping by epigenome prediction</article-title>
<source/>PLoS Comput Biol
          <year>2007</year>
<volume>3</volume>
<fpage>e110</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.0030110</pub-id>
<pub-id pub-id-type="pmid">17559301</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin-Herranz</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>AJM</given-names>
</name>
<name>
<surname>Krueger</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Thornton</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Reik</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Stubbs</surname>
<given-names>TM</given-names>
</name>
</person-group>
<article-title>cuRRBS: simple and robust evaluation of enzyme combinations for reduced representation approaches</article-title>
<source/>Nucleic Acids Res
          <year>2017</year>
<volume>45</volume>
<fpage>11559</fpage>
<lpage>11569</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkx814</pub-id>
<pub-id pub-id-type="pmid">29036576</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<mixed-citation publication-type="other">Consortium NREM. Roadmap epigenomics chromatin state model: raw data. <ext-link ext-link-type="uri" xlink:href="https://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/imputed12marks/jointModel/final/catMat/hg19_chromHMM_imputed25.gz">https://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/imputed12marks/jointModel/final/catMat/hg19_chromHMM_imputed25.gz</ext-link>. <ext-link ext-link-type="uri" xlink:href="https://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/imputed12marks/jointModel/final/catMat/hg19_chromHMM_imputed25.gz">https://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/imputed12marks/jointModel/final/catMat/hg19_chromHMM_imputed25.gz</ext-link>.</mixed-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<mixed-citation publication-type="other">Consortium NREM. Roadmap epigenomics chromatin state model: emission parameters. <ext-link ext-link-type="uri" xlink:href="https://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/imputed12marks/jointModel/final/emissions_25_imputed12marks.png">https://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/imputed12marks/jointModel/final/emissions_25_imputed12marks.png</ext-link>. <ext-link ext-link-type="uri" xlink:href="https://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/imputed12marks/jointModel/final/emissions_25_imputed12marks.png">https://egg2.wustl.edu/roadmap/data/byFileType/chromhmmSegmentations/ChmmModels/imputed12marks/jointModel/final/emissions_25_imputed12marks.png</ext-link>.</mixed-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<mixed-citation publication-type="other">Wang Z, Shi L. Epigenome analysis of whole blood samples in Chinese children. GSE104812. Gene Expression Omnibus. 2017. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE104812">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE104812</ext-link>.</mixed-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<mixed-citation publication-type="other">Ritz B, Horvath S. Genome wide DNA methylation study of Parkinsonâs disease in whole blood samples. GSE111629. Gene Expression Omnibus. 2018. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111629">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111629</ext-link>.</mixed-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<mixed-citation publication-type="other">Brucato M, Sobreira N, Zhang L, Ladd-Acosta C, Ongaco C, Romm J, et al. Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities. GSE116300. Gene Expression Omnibus. 2018. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116300">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116300</ext-link>.</mixed-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<mixed-citation publication-type="other">Reinius L, Acevedo N, Joerink M, Pershagen G, DahlÃ©n S, Greco D, et al. Differential DNA methylation in purified human blood cells. GSE35069. Gene Expression Omnibus. 2012. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35069">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35069</ext-link>.</mixed-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<mixed-citation publication-type="other">Zhang K, Ideker T. Genome-wide methylation profiles reveal quantitative views of human aging rates. GSE40279. Gene Expression Omnibus. 2012. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40279">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40279</ext-link>.</mixed-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<mixed-citation publication-type="other">Warren S, Chopra P. Genome-wide analysis identifies aberrant methylation in Fragile X syndrome is specific to the FMR1 locus. GSE41273. Gene Expression Omnibus. 2013. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41273">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41273</ext-link>.</mixed-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<mixed-citation publication-type="other">Liu Y, Feinberg A. Differential DNA methylation in rheumatoid arthritis. GSE42861. Gene Expression Omnibus. 2013. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42861">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42861</ext-link>.</mixed-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<mixed-citation publication-type="other">Polidoro S, Campanella G, Krogh V, Palli D, Panico S, Tumino R, et al. EPIC-Italy at HuGeF. GSE51032. Gene Expression Omnibus. 2013. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51032">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51032</ext-link>.</mixed-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<mixed-citation publication-type="other">Prickett A, Ishida M, BÃ¶hm S, Frost J, Puszyk W, Abu-Amero S, et al. Genomewide methylation analysis in Silver Russell syndrome patients. GSE55491. Gene Expression Omnibus. 2015. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55491">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55491</ext-link>.</mixed-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<mixed-citation publication-type="other">Milani L, Peterson P. Age-related profiling of DNA methylation in CD8+ T cells reveals changes in immune response and transcriptional regulator genes. GSE59065. Gene Expression Omnibus. 2015. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE59065">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE59065</ext-link>.</mixed-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<mixed-citation publication-type="other">Tan Q, Christiansen L, Frost M. Epigenetic signature of birth-weight discordance in Danish twins. GSE61496. Gene Expression Omnibus. 2014. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61496">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61496</ext-link>.</mixed-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<mixed-citation publication-type="other">Choufani S, Turinsky A, Weksberg R. NSD1 mutations generate a genome-wide DNA methylation signature. GSE74432. Gene Expression Omnibus. 2015. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74432">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74432</ext-link>.</mixed-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<mixed-citation publication-type="other">Koestler D, Christensen B, Wiencke J, Kelsey K. DNA methylation profiling of whole blood and reconstructed mixtures of purified leukocytes isolated from human adult blood. GSE77797. Gene Expression Omnibus. 2016. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77797">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77797</ext-link>.</mixed-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<mixed-citation publication-type="other">Li Yim A, Duijvis N, Zhao J, de Jonge W, DâHaens G, Mannens M, et al. Peripheral blood methylation profiling of female Crohnâs disease patients. GSE81961. Gene Expression Omnibus. 2016. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81961">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81961</ext-link>.</mixed-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<mixed-citation publication-type="other">Butcher D, Choufani S, Turinsky A, Weksberg R. CHARGE and Kabuki syndromes: gene-specific DNA methylation signatures. GSE97362. Gene Expression Omnibus. 2017. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97362">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97362</ext-link>.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>